≡ Risteys
FG R12 + FR

Documentation Changelog GitHub Contact & Feedback

Gout due to impairment of renal function

DOID EFO Endpoint Browser PheWeb

GOUT_KIDNEY

gout: A condition characterized by painful swelling of the joints, which is caused by deposition of urate crystals.

Suggest a new description

Endpoint definition

↥

Endpoint definition steps

FinnGen

Phenotype data

520210

1. Apply sex-specific rule

None

520210

2. Check conditions

None

520210

3. Check pre-conditions, main-only, mode, registry filters

Registry filters:

  • Hospital discharge: ICD-10 — M10.3
  • Cause of death: ICD-10 — M10.3

2 out of 7 registries used, show all original rules.

340

4. Check minimum number of events

None

340

5. Include endpoints

None

340

6. Filter based on genotype QC (FinnGen only)

340

Control definitions (FinnGen only)

Control exclude
GOUT

Extra metadata

First used in FinnGen datafreeze
DF2
Parent code in ICD-10
M10
Name in latin
Arthritis urica ex insufficientia renali

Case counts by codes

↥

FinnGen case counts by registry codes:

generic upset plot

Upset plot

Full data table

Summary Statistics

↥

-FinRegistry-

Key figures

All Female Male
Number of individuals
Whole population 1900 646 1244
Only index persons 1736 586 1150
Unadjusted period prevalence (%)
Whole population 0.03 0.02 0.03
Only index persons 0.04 0.02 0.04
Median age at first event (years)
Whole population 73.96 77.27 72.23
Only index persons 73.66 76.82 72.05

-FinnGen-

Key figures

All Female Male
Number of individuals 340 90 250
Unadjusted period prevalence (%) 0.09 0.03 0.11
Median age at first event (years) 70.61 71.89 70.15

-FinRegistry-

Age distribution of first events

-FinnGen-

Age distribution of first events

-FinRegistry-

Year distribution of first events

-FinnGen-

Year distribution of first events

-FinRegistry-

Cumulative Incidence Function

-FinnGen-

Cumulative Incidence Function

CodeWAS (R11)

↥

CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.

This is a new tool, please reach out using the contact form for feedback and improvement ideas.

First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log10(p-value) ≥ 6.

Matched cohort

Matched cases
309
Matched controls
3088
Code
Vocabulary
Description
Odds Ratio
-log10(p)
N matched cases
N matched controls
M10.3
ICD-10 Finland
Gout due to impairment of renal function
+∞
323.0
309
*
M04AA01
ATC
allopurinol; systemic
86.6
210.6
272
241
N18.9
ICD-10 Finland
Chronic kidney disease, unspecified
42.0
148.4
196
122
M10.9
ICD-10 Finland
Gout, unspecified
65.9
145.4
167
54
123
Kela drug reimbursment
Chronic disorders of vitamin D metabolism
90.2
137.2
148
31
138
Kela drug reimbursment
Severe anaemia associated with chronic renal failure
85.5
124.9
136
28
A11CC03
ATC
alfacalcidol; systemic
78.8
115.1
127
27
N18.8
ICD-10 Finland
Other chronic renal failure
50.3
113.3
137
48
C03CA01
ATC
furosemide; systemic
13.7
88.3
251
741
A12AA04
ATC
calcium carbonate; oral
66.5
85.4
97
21
TK800
NOMESCO Finland
Hemodialysis
39.8
75.1
95
34
Z94.0
ICD-10 Finland
Kidney transplant status
141.8
64.8
67
6
212
Kela drug reimbursment
Gout
+∞
62.6
58
*
L04AA06
ATC
mycophenolic acid; systemic
69.1
61.9
70
13
B03XA02
ATC
darbepoetin alfa; parenteral
38.1
61.3
78
27
N18.0
ICD-10 Finland
End-stage renal disease
48.1
61.3
74
20
M10.0
ICD-10 Finland
Idiopathic gout
64.1
61.2
70
14
127
Kela drug reimbursment
Transplant complication
92.6
60.9
66
9
205
Kela drug reimbursment
Chronic hypertension
7.7
59.9
218
730
Z49.1
ICD-10 Finland
Extracorporeal dialysis
52.7
59.1
70
17
PBL10
NOMESCO Finland
Construction of arteriovenous fistula from radial artery
68.1
57.4
65
12
KAS10
NOMESCO Finland
Allogenic transplantation of kidney from cadaver donor
173.8
55.9
57
*
I15.1
ICD-10 Finland
Hypertension secondary to other renal disorders
92.4
55.3
60
8
N19
ICD-10 Finland
Unspecified kidney failure
20.0
51.1
79
52
Z49.0
ICD-10 Finland
Preparatory care for dialysis
63.1
49.7
57
11
190
Kela drug reimbursment
Lanthanum carbonate, sevelamer and sucroferric oxyhydroxide
63.5
46.3
53
10
C08CA01
ATC
amlodipine; oral
5.8
44.8
216
885
137
Kela drug reimbursment
Uraemia requiring dialysis
74.1
44.7
50
8
I50.9
ICD-10 Finland
Heart failure, unspecified
6.7
43.4
133
311
KA2AE
NOMESCO Finland
Ultrasound examination transplanted kidney
235.2
40.9
41
*
L04AD02
ATC
tacrolimus; systemic (calcineurin inhibitors)
228.6
39.8
40
*
N25.8
ICD-10 Finland
Other disorders resulting from impaired renal tubular function
152.4
38.7
40
*
TPH15
NOMESCO Finland
Insertion of central venous catheter through external or internal jugular vein
10.4
38.4
80
100
V03AE01
ATC
polystyrene sulfonate; oral
45.0
35.4
43
11
A12AX
ATC
Calcium, combinations with vitamin D and/or other drugs
4.7
34.5
166
612
N17.9
ICD-10 Finland
Acute renal failure, unspecified
12.9
34.4
63
60
288
Kela drug reimbursment
Febuxostat
+∞
34.0
32
*
L04AD01
ATC
ciclosporin; systemic
35.4
33.6
43
14
C02AC05
ATC
moxonidine; oral
9.9
32.9
70
89
B05DA
ATC
Isotonic solutions
80.9
32.6
36
5
KH1AE
NOMESCO Finland
Urinary tract ultrasound examination
10.1
32.5
68
84
M04AA03
ATC
febuxostat; oral
+∞
31.8
30
*
A46
ICD-10 Finland
Erysipelas
5.5
31.4
108
273
JN3AE
NOMESCO Finland
Abdominal ultrasound examination
5.4
31.3
111
290
H02AB04
ATC
methylprednisolone; systemic
5.8
31.2
101
237
A49.9
ICD-10 Finland
Bacterial infection, unspecified
6.4
31.1
91
188
H02AB06
ATC
prednisolone; systemic
4.2
30.9
214
1074
I10
ICD-10 Finland
Essential (primary) hypertension
5.1
30.8
261
1586
GD1AA
NOMESCO Finland
Thorax X-ray examination
4.2
30.1
215
1095
B03XA03
ATC
methoxy polyethylene glycol-epoetin beta; parenteral
63.3
29.8
34
6
N08.39*E11.2
ICD-10 Finland
Non-insulin-dependent diabetes mellitus - Diabetic nephropathy
28.5
29.6
40
16
M10
ICD-10 Finland
Gout
10.8
29.6
59
66
A10BH05
ATC
linagliptin; oral
10.1
29.0
60
72
I50.0
ICD-10 Finland
Congestive heart failure
6.9
28.9
78
143
349
Kela drug reimbursment
Febuxostat
+∞
28.6
27
*
C08CA13
ATC
lercanidipine; oral
5.2
28.4
103
272
C09CA01
ATC
losartan; oral
4.2
28.2
142
519
C09AA02
ATC
enalapril; systemic
4.3
28.0
133
461
Z49.2
ICD-10 Finland
Other dialysis
42.1
27.7
34
9
B05DB
ATC
Hypertonic solutions
68.5
27.5
31
5
KA1AE
NOMESCO Finland
Kidney ultrasound examination
16.9
27.5
44
30
N10
ICD-10 Finland
Acute tubulo-interstitial nephritis
5.5
27.4
91
216
KA2AT
NOMESCO Finland
Biopsy of transplanted kidney with ultrasound guidance
106.2
27.1
29
*
M13.9
ICD-10 Finland
Arthritis, unspecified
9.2
27.1
59
77
E11.2
ICD-10 Finland
Type 2 diabetes mellitus, with renal complications
10.1
26.7
55
65
L04AA01
ATC
[U] ciclosporin; systemic
34.5
26.5
34
11
320
Kela drug reimbursment
Lanthanum carbonate, sevelamer and sucroferric oxyhydroxide
79.4
26.3
29
*
E11.7
ICD-10 Finland
Type 2 diabetes mellitus, with multiple complications
7.9
26.1
63
97
196
Kela drug reimbursment
Paricalcitol and cinacalcet
76.5
25.2
28
*
Q61.2
ICD-10 Finland
Polycystic kidney, autosomal dominant
98.2
25.1
27
*
B03XA01
ATC
erythropoietin; parenteral
38.0
24.8
31
9
H05BX01
ATC
cinacalcet; oral
73.5
24.2
27
*
V03AE02
ATC
sevelamer; oral
45.5
24.1
29
7
GD1UA
NOMESCO Finland
Thorax X-ray examination outside radiological department
4.2
24.0
108
347
JAK10
NOMESCO Finland
Laparotomy and insertion of peritoneal dialysis catheter
51.1
23.7
28
6
PG1DE
NOMESCO Finland
Other extensive ultrasound examination of artery
8.8
23.5
52
69
J01EE01
ATC
sulfamethoxazole and trimethoprim; systemic
7.8
23.3
56
85
103
Kela drug reimbursment
Diabetes, insulin-treated
3.5
23.3
150
650
C08CA02
ATC
felodipine; oral
5.2
22.9
78
187
B01AA03
ATC
warfarin; systemic
3.6
22.8
135
545
TPH04
NOMESCO Finland
Cathetrisation of vein
3.8
22.8
120
439
I12.0
ICD-10 Finland
Hypertensive renal disease with renal failure
23.6
22.6
32
15
A10AC01
ATC
insulin (human); parenteral (insulins and analog. for injection, intermediate-acting)
6.0
22.4
66
133
215
Kela drug reimbursment
Diabetes, non-insulin-treated
3.6
22.3
134
542
J18.9
ICD-10 Finland
Pneumonia, unspecified
3.5
21.7
137
574
C07AG02
ATC
carvedilol; oral
6.0
21.7
64
129
JN3AD
NOMESCO Finland
Abdominal CT examination
5.6
21.4
67
145
TK820
NOMESCO Finland
Peritoneal dialysis
45.1
20.8
25
6
A10AE04
ATC
insulin glargine; parenteral
5.3
20.5
67
152
C07AB07
ATC
bisoprolol; oral
3.2
20.2
207
1208
E11.9
ICD-10 Finland
Type 2 diabetes mellitus, without complications
3.3
19.7
131
563
ZX120
NOMESCO Finland
Intravenous
5.1
19.3
66
157
V03AE03
ATC
lanthanum carbonate; oral
58.9
19.2
22
*
FM1EE
NOMESCO Finland
Extensive structural and functional ultrasound examination of heart
3.4
18.9
117
474
U14
ICPC
Kidney symptom/complaint
17.6
18.7
29
18
J01DB01
ATC
cefalexin; oral
4.2
18.4
276
2052
ZXD05
NOMESCO Finland
Urgent procedure
3.1
18.3
140
652
E11.8
ICD-10 Finland
Type 2 diabetes mellitus, with unspecified complications
4.3
17.8
72
203
N08.39*E10.2
ICD-10 Finland
Insulin-dependent diabetes mellitus - Diabetic nephropathy
30.9
17.7
23
8
GD1PA
NOMESCO Finland
X-ray examination of the lungs in one projection
4.6
17.3
65
170
I50.1
ICD-10 Finland
Left ventricular failure
6.1
17.3
49
93
3AC01
NOMESCO Finland
NA
27.4
17.2
23
9
PH2AE
NOMESCO Finland
Ultrasound examination of lower leg veins
4.2
17.0
71
205
C10AA05
ATC
atorvastatin; oral
2.8
17.0
174
966
321
Kela drug reimbursment
Paricalcitol and cinacalcet
67.1
16.9
19
*
B01AB10
ATC
tinzaparin; parenteral
5.7
16.7
50
101
TJA35
NOMESCO Finland
Removal of peritoneal dialysis catheter
95.2
16.7
18
*
R4110
NOMESCO Finland
Physiotherapy
3.0
16.7
124
559
A10AB05
ATC
insulin aspart; parenteral (insulins and analog. for injection, fast-acting)
5.2
16.7
54
120
J01FF01
ATC
clindamycin; systemic
3.1
16.6
119
524
T92
ICPC
Gout
16.6
16.5
26
17
SPAT1262
SPAT
Handing over of treatment supplies
3.3
16.3
98
379
GD1QA
NOMESCO Finland
Supine thorax X-ray examination
3.4
16.3
92
341
D64.9
ICD-10 Finland
Anaemia, unspecified
4.1
15.8
67
196
A12AA12
ATC
[U] calcium acetate anhydrous; systemic
89.7
15.7
17
*
N03.9
ICD-10 Finland
Chronic nephritic syndrome, unspecified
89.7
15.7
17
*
N25.0
ICD-10 Finland
Renal osteodystrophy
40.3
15.6
19
5
R50.9
ICD-10 Finland
Fever, unspecified
3.8
15.4
73
235
C10AA01
ATC
simvastatin; oral
2.7
15.3
196
1213
NA3AA
NOMESCO Finland
Lumbar spine X-ray examination without contrast
4.4
15.2
59
158
N08.2*D89.80
ICD-10 Finland
Immunoglobulin A (IgA) nephropathy
33.6
15.0
19
6
I70.2
ICD-10 Finland
Atherosclerosis of arteries of extremities
3.8
14.8
69
218
A10BB12
ATC
glimepiride; oral
4.5
14.8
55
141
A02BC02
ATC
pantoprazole; systemic
2.7
14.7
227
1550
TPX10
NOMESCO Finland
Implantation of vascular injection port
8.1
14.6
33
45
SPAT1148
SPAT
Treatment of chronic ulcer or burn
3.5
14.6
78
275
I48
ICD-10 Finland
Atrial fibrillation and flutter
2.8
14.6
126
615
N02AA59
ATC
codeine, combinations excl. psycholeptics; systemic
2.6
14.5
172
1006
Z3231
NOMESCO Finland
Registered nurse
2.8
14.5
120
571
J01MA02
ATC
ciprofloxacin; systemic
2.6
14.3
161
912
N08.39
ICD-10 Finland
Glomerular disorders in diabetes mellitus microalbuminuria
44.7
14.2
17
*
N02AX02
ATC
tramadol; systemic, rectal
2.5
13.8
167
981
FM1AE
NOMESCO Finland
Standard cardiac ultrasound examination
3.0
13.6
95
403
UJD10
NOMESCO Finland
Esophagoscopy, gastroscopy and duodenoscopy
2.6
13.5
126
637
WW200
NOMESCO Finland
Immunization
8.5
13.4
29
37
TK810
NOMESCO Finland
Hemofiltration
23.8
13.0
18
8
L28
ICPC
Limited function/disability (L)
3.2
13.0
78
296
KA3AT
NOMESCO Finland
Biopsy of kidney with ultrasound guidance
14.9
12.9
21
15
R06.0
ICD-10 Finland
Dyspnoea
2.7
12.9
105
488
A41.5
ICD-10 Finland
Sepsis due to other Gram-negative organisms
7.4
12.7
30
44
XPX99
NOMESCO Finland
Other diagnostic examination of periferal vessel
4.4
12.7
47
120
N03.0
ICD-10 Finland
Chronic nephritic syndrome, minor glomerular abnormality
+∞
12.6
12
*
N02BE01
ATC
paracetamol; systemic, rectal
3.5
12.6
278
2228
E87.5
ICD-10 Finland
Hyperkalaemia
12.4
12.5
22
19
A10AB01
ATC
insulin (human); parenteral (insulins and analog. for injection, fast-acting)
8.0
12.5
28
38
S97
ICPC
Chronic ulcer skin
4.5
12.2
44
109
A09
ICD-10 Finland
Other gastroenteritis and colitis of infectious and unspecified origin
3.3
12.2
70
255
L04AX01
ATC
azathioprine; systemic
6.4
12.2
32
55
T90
ICPC
Diabetes non-insulin dependent
2.6
12.1
109
531
Z71.3
ICD-10 Finland
Dietary counselling and surveillance
5.8
12.1
34
64
E10.7
ICD-10 Finland
Type 1 diabetes mellitus, With multiple complications
11.2
12.0
22
21
R2130
NOMESCO Finland
Counselling and guidance which enhance independent living
4.1
11.9
48
133
A10BH01
ATC
sitagliptin; oral
3.7
11.8
55
172
B01AC04
ATC
clopidogrel; oral
2.8
11.8
88
384
NK4XE
NOMESCO Finland
Joint ultrasound examination not elsewhere classified
6.0
11.7
32
58
TPH90
NOMESCO Finland
Removal of fixed intravenous catheter
10.7
11.7
22
22
N04.1
ICD-10 Finland
Nephrotic syndrome, focal and segmental glomerular lesions
67.5
11.7
13
*
C07AB02
ATC
metoprolol; systemic
2.6
11.5
102
491
D638, N189
ICD-10 Finland
NA
+∞
11.5
11
*
KA9AE
NOMESCO Finland
Ultrasound examination transplanted kidney
124.3
11.5
12
*
PBM10
NOMESCO Finland
Closure of arteriovenous fistula of radial artery
36.5
11.4
14
*
Q61.3
ICD-10 Finland
Polycystic kidney, unspecified
36.5
11.4
14
*
K65.0
ICD-10 Finland
Acute peritonitis
17.9
11.3
17
10
N18
ICD-10 Finland
Chronic kidney disease
17.9
11.3
17
10
TNX10
NOMESCO Finland
Arthrocentesis, unspecified region, unspecified region
5.2
11.3
35
74
L17
ICPC
Foot/toe symptom/complaint
2.6
11.3
99
475
R60.0
ICD-10 Finland
Localized oedema
3.4
11.2
58
197
NH3AA
NOMESCO Finland
Foot and toes X-ray examination
4.6
11.1
39
94
C02CA01
ATC
prazosin; oral
7.4
11.1
26
38
E78.01
ICD-10 Finland
Pure hypercholesterolaemia
2.7
11.1
93
431
I11.9
ICD-10 Finland
Hypertensive heart disease without (congestive) heart failure
5.7
10.9
31
59
I25.1
ICD-10 Finland
Atherosclerotic heart disease
2.4
10.9
117
622
J01MA14
ATC
moxifloxacin; systemic
3.6
10.8
51
161
QDB10
NOMESCO Finland
Major dressing of wound of skin of lower limb
4.6
10.8
38
92
PB1DE
NOMESCO Finland
Upper extremity arteries ultrasound examination with Doppler method
22.4
10.8
15
7
A10AE05
ATC
insulin detemir; parenteral
4.8
10.7
36
83
C03DA01
ATC
spironolactone; oral
3.1
10.7
63
234
N18.5
ICD-10 Finland
Chronic kidney disease, stage 5
62.1
10.7
12
*
FN1AC
NOMESCO Finland
Angiography of heart and/or coronary arteries
2.4
10.6
109
565
ZXA00
NOMESCO Finland
Right side
2.4
10.6
114
604
NK6QA
NOMESCO Finland
Measurement of bone density from tow or more locations with X-ray
4.7
10.6
36
84
Z2446
NOMESCO Finland
Social worker
4.6
10.6
37
89
CJE20
NOMESCO Finland
Phakoemulsification with implantation of artificial lens in posterior chamber
2.3
10.5
128
719
Z94.9
ICD-10 Finland
Transplanted organ and tissue status, unspecified
113.6
10.5
11
*
WW500
NOMESCO Finland
Blood transfusion
5.6
10.5
30
58
A41.0
ICD-10 Finland
Sepsis due to Staphylococcus aureus
9.3
10.4
21
24
ZXE10
NOMESCO Finland
More than one and less than three hours
2.3
10.4
137
800
RD210
NOMESCO Finland
NA
11.2
10.4
19
18
Z95.0
ICD-10 Finland
Presence of electronic cardiac devices
4.5
10.4
37
91
JN4AD
NOMESCO Finland
Body CT examination
3.8
10.3
45
133
PG5DE
NOMESCO Finland
Ultrasound examination of injection gate to artery or vein with Doppler method
24.3
10.3
14
6
ZXA05
NOMESCO Finland
Left side
2.4
10.1
108
569
A12BA01
ATC
potassium chloride; oral
4.3
10.0
37
94
N18.4
ICD-10 Finland
Chronic kidney disease, stage 4
41.5
10.0
12
*
A10AB04
ATC
insulin lispro; parenteral (insulins and analog. for injection, fast-acting)
8.6
10.0
21
26
ZXD30
NOMESCO Finland
Difficulties in perfomrming procedure
5.1
10.0
31
66
PBL09
NOMESCO Finland
Construction of arteriovenous fistula from brachial artery
27.0
9.9
13
5
B01AB05
ATC
enoxaparin; parenteral
2.3
9.9
118
654
E10.9
ICD-10 Finland
Type 1 diabetes mellitus, Without complications
6.6
9.6
24
39
R11
ICD-10 Finland
Nausea and vomiting
3.9
9.6
39
109
207
Kela drug reimbursment
Chronic arrhythmias
2.6
9.6
76
341
E10.2
ICD-10 Finland
Type 1 diabetes mellitus, With renal complications
18.2
9.5
14
8
PG5RT
NOMESCO Finland
PTA of arterio-venous shunt for dialysis
31.1
9.5
12
*
N08.2
ICD-10 Finland
Glomerular disorders in blood diseases and disorders involving the immune mechanism
103.0
9.5
10
*
A10AA02
ATC
NA
6.8
9.4
23
36
N03.8
ICD-10 Finland
Chronic nephritic syndrome, other
+∞
9.4
9
*
E21.1
ICD-10 Finland
Secondary hyperparathyroidism, not elsewhere classified
+∞
9.4
9
*
XCK10
NOMESCO Finland
Photography of fundus of eye
3.3
9.4
49
168
B99
ICD-10 Finland
Other and unspecified infectious diseases
7.1
9.3
22
33
M79.6
ICD-10 Finland
Pain in limb
2.2
9.2
119
679
WX892
NOMESCO Finland
Monitored bed care
3.4
9.2
46
152
C01DA14
ATC
isosorbide mononitrate; oral
2.5
9.2
83
398
PH1AE
NOMESCO Finland
Ultrasound examination of upper extremity veins
10.5
9.1
17
17
K57.3
ICD-10 Finland
Diverticular disease of large intestine without perforation or abscess
2.6
9.1
75
339
ZXE20
NOMESCO Finland
More than three and less than five hours
2.7
9.0
67
287
A41.9
ICD-10 Finland
Sepsis, unspecified
5.2
8.9
27
56
C09CA06
ATC
candesartan; oral
2.5
8.9
81
389
XF400
NOMESCO Finland
ECG with 12 standard connections
2.5
8.9
79
375
I20.09
ICD-10 Finland
Unstable angina
3.8
8.8
37
106
I25.0
ICD-10 Finland
Atherosclerotic cardiovascular disease, so described
3.7
8.8
39
117
K07
ICPC
Swollen ankles/oedema
4.9
8.7
28
62
D89.80
ICD-10 Finland
Immunoglobulin A (IgA) deposits in organisms
51.4
8.7
10
*
R53
ICD-10 Finland
Malaise and fatigue
2.5
8.6
75
351
J01MA12
ATC
levofloxacin; systemic
2.4
8.6
83
408
TQX10
NOMESCO Finland
Biopsy of skin and subcutaneous tissue
3.2
8.5
47
165
L97
ICD-10 Finland
Ulcer of lower limb, not elsewhere classified
5.3
8.5
25
50
H3603, E103
ICD-10 Finland
NA
20.7
8.5
12
6
UJF32
NOMESCO Finland
Coloscopy
2.2
8.5
100
544
SPAT1230
SPAT
Aid fitting and borrowing and monitoring of use
2.6
8.5
67
297
A10AA01
ATC
NA
8.2
8.5
18
23
E86
ICD-10 Finland
Volume depletion
6.5
8.5
21
34
H05BX02
ATC
paricalcitol; systemic
92.4
8.5
9
*
58209
ICD-8 Finland
Chronic nephritis, Unspecified
92.4
8.5
9
*
N03.3
ICD-10 Finland
Chronic nephritic syndrome, diffuse mesangial proliferative glomerulonephritis
92.4
8.5
9
*
Z3226
NOMESCO Finland
Physiotherapist
2.4
8.4
78
376
JN3AA
NOMESCO Finland
Abdominal X-ray examination without contrast
3.9
8.4
34
95
RS220
NOMESCO Finland
NA
11.2
8.4
15
14
N11.8
ICD-10 Finland
Other chronic tubulo-interstitial nephritis
+∞
8.4
8
*
Z99.2
ICD-10 Finland
Dependence on renal dialysis
+∞
8.4
8
*
AA1AD
NOMESCO Finland
CT of head and brain
2.3
8.4
95
506
A04.7
ICD-10 Finland
Enterocolitis due to Clostridium difficile
6.2
8.1
21
36
J01DA01
ATC
[U] cefalexin; systemic
2.0
8.1
193
1392
WX722
NOMESCO Finland
PEEP
4.1
8.1
31
82
WX610
NOMESCO Finland
Patient controlled analgesia
34.3
8.1
10
*
XF655
NOMESCO Finland
Measurement of heart muscle perfusion with exercise
4.9
8.0
25
54
I50
ICD-10 Finland
Heart failure
5.7
8.0
22
41
E66.8
ICD-10 Finland
Other obesity
6.4
8.0
20
33
M01AB01
ATC
indometacin; systemic, rectal
3.1
8.0
44
155
WX202
NOMESCO Finland
Supraclavicular plexus blockade
11.2
7.9
14
13
DM1QA
NOMESCO Finland
Paranasal sinuses X-ray examination in one projection
4.6
7.8
26
60
AN1
HP
Coronary angiography
2.6
7.8
63
281
285
Kela drug reimbursment
Dulaglutide, exenatide, liraglutide, lixisenatide and semaglutide (adults)
4.4
7.8
27
65
ZXD10
NOMESCO Finland
Scheduled procedure
2.0
7.8
133
842
NG1AE
NOMESCO Finland
Knee joint ultrasound exmination
15.5
7.8
12
8
R31
ICD-10 Finland
Unspecified haematuria
2.8
7.8
51
202
N02AE01
ATC
buprenorphine; parenteral, sublingual, transdermal
2.7
7.8
57
241
V03AE04
ATC
calcium acetate and magnesium carbonate; systemic
46.1
7.7
9
*
D50.0
ICD-10 Finland
Iron deficiency anaemia secondary to blood loss (chronic)
5.4
7.7
22
43
H43.1
ICD-10 Finland
Vitreous haemorrhage
5.7
7.7
21
39
QX2XE
NOMESCO Finland
Ultrsound examination of soft tissue not elsewhere classified
6.0
7.7
20
35
A08
ICPC
Swelling
4.7
7.6
25
57
A41.1
ICD-10 Finland
Sepsis due to other specified staphylococcus
25.7
7.6
10
*
C09BA02
ATC
enalapril and diuretics; systemic
3.0
7.6
46
172
WX002
NOMESCO Finland
Sedation and analgesia
2.3
7.6
77
388
WX408
NOMESCO Finland
General anesthesy, balanced
2.1
7.5
102
585
N18.3
ICD-10 Finland
Chronic kidney disease, stage 3
81.9
7.4
8
*
TJA33
NOMESCO Finland
Percutaneous introduction of peritoneal dialysis catheter
81.9
7.4
8
*
R4190
NOMESCO Finland
Nutritional therapy
5.4
7.4
21
41
E10.3
ICD-10 Finland
Type 1 diabetes mellitus, With ophthalmic complications
11.2
7.4
13
12
A10BH02
ATC
vildagliptin; oral
6.1
7.3
19
33
D50.9
ICD-10 Finland
Iron deficiency anaemia, unspecified
3.2
7.3
37
124
L04AA05
ATC
[U] tacrolimus; systemic
+∞
7.3
7
*
N03.1
ICD-10 Finland
Chronic nephritic syndrome, focal and segmental glomerular lesions
+∞
7.3
7
*
7151
FHL
Kidney transplantation
+∞
7.3
7
*
C08DB01
ATC
diltiazem; oral
3.4
7.3
34
107
ZXE04
NOMESCO Finland
Procedure duration 30 to 39 minutes
4.0
7.3
28
75
KBV00
NOMESCO Finland
Insertion of stent into ureter
16.2
7.3
11
7
SPAT1255
SPAT
Intravenous administration of medicine
3.7
7.2
30
86
A41.8
ICD-10 Finland
Other specified sepsis
8.2
7.2
15
19
ZXE40
NOMESCO Finland
More than seven and less than nine hours
6.3
7.2
18
30
PG5AC
NOMESCO Finland
Contrast examination of injection gate to artery or vein
30.8
7.2
9
*
PBU84
NOMESCO Finland
Plastic repair of arteriovenous fistula from artery of upper extremity
30.8
7.2
9
*
A28
ICPC
Limited function/disability NOS
2.3
7.2
69
339
OAB74
NOMESCO Finland
Nutritional guidance related to treatment and rehabilitation for medical condition
20.6
7.2
10
5
I42.0
ICD-10 Finland
Dilated cardiomyopathy
5.0
7.2
22
47
S18
ICPC
Laceration/cut
1.9
7.2
144
958
206
Kela drug reimbursment
Chronic coronary artery disease and dyslipidaemia associated with chronic coronary artery disease
2.1
7.1
93
524
R80
ICD-10 Finland
Isolated proteinuria
12.4
7.1
12
10
TPH07
NOMESCO Finland
Cathetrisation of artery
2.6
7.1
54
234
C02EA02
ATC
NA
3.7
7.0
30
88
D12.6
ICD-10 Finland
Benign neoplasm: Colon, unspecified
3.7
7.0
30
88
WX882
NOMESCO Finland
High dependency care
4.8
7.0
22
48
N02AJ06
ATC
codeine and paracetamol; systemic
2.0
7.0
115
708
25000
ICD-8 Finland
Diabetes mellitus, Sine complicatione
6.1
7.0
18
31
UJF30
NOMESCO Finland
Ileoscopy through colon
3.1
7.0
39
139
Z2221
NOMESCO Finland
Medical doctor
2.1
7.0
98
569
FM1BE
NOMESCO Finland
Cardiac ultrasound examination through oesophagus
3.4
6.9
32
101
E66.00
ICD-10 Finland
Metabolic syndrome
3.6
6.9
30
90
NF1AE
NOMESCO Finland
Hip joint ultrasound examination
6.4
6.9
17
28
S81.8
ICD-10 Finland
Open wound of other parts of lower leg
4.9
6.8
21
45
SPAT1149
SPAT
Suture or treatment of traumatic wound
2.5
6.8
57
258
XFP20
NOMESCO Finland
Check up of cardiac pacemaker
3.1
6.8
36
125
K65.9
ICD-10 Finland
Peritonitis, unspecified
40.9
6.8
8
*
J15.9
ICD-10 Finland
Bacterial pneumonia, unspecified
2.7
6.8
47
194
E11.00
ICD-10 Finland
Non-insulin dependent diabetes diabetic hypoglycaemic coma
4.1
6.8
25
65
UKC02
NOMESCO Finland
Cystoscopy
2.2
6.7
70
356
B02.9
ICD-10 Finland
Zoster without complication
3.7
6.7
28
81
C09AA05
ATC
ramipril; oral
2.0
6.7
104
628
Z03.5
ICD-10 Finland
Observation for other suspected cardiovascular diseases
3.4
6.7
31
98
E10.00
ICD-10 Finland
Insulin-dependent diabetes diabetic hypoglycemic coma
12.6
6.6
11
9
D48.5
ICD-10 Finland
Neoplasm of uncertain or unknown behaviour: Skin
3.5
6.6
29
88
L08.9
ICD-10 Finland
Local infection of skin and subcutaneous tissue, unspecified
5.9
6.5
17
30
346
Kela drug reimbursment
Dulaglutide, exenatide, liraglutide, lixisenatide and semaglutide (adults)
4.3
6.5
23
57
201
Kela drug reimbursment
Chronic cardiac insufficiency
3.4
6.5
30
94
J01CA04
ATC
amoxicillin; systemic
2.0
6.5
232
1865
SAA03
NOMESCO Finland
Extended examination of mouth
2.0
6.5
107
656
SPAT1254
SPAT
Administration of medicine
2.3
6.5
60
288
N02AA05
ATC
oxycodone; systemic
2.3
6.5
60
288
E66.01
ICD-10 Finland
Obesity due to excess calories
3.8
6.5
26
73
C01DA08
ATC
isosorbide dinitrate; oral, oral aerosol, sublingual, transdermal
2.0
6.5
99
590
N05.9
ICD-10 Finland
Unspecified nephritic syndrome, unspecified
71.2
6.4
7
*
H02AB07
ATC
prednisone; oral
2.4
6.4
57
266
SPAT1325
SPAT
Vaccination
1.9
6.4
119
763
WX203
NOMESCO Finland
Infraclavicular plexus blockade
5.7
6.4
17
31
H36.00
ICD-10 Finland
Diabetic background retinopathy
8.4
6.4
13
16
Z3229
NOMESCO Finland
Other healthcare associate professional
2.8
6.4
40
154
E78.5
ICD-10 Finland
Hyperlipidaemia, unspecified
2.6
6.3
46
192
WW400
NOMESCO Finland
Plasmaferesis
+∞
6.3
6
*
5828A
ICD-9 Finland
Chronic glomerulonephritis, With other specified pathological lesion in kidney[GLOMERULONEPHRITIS CHRONICA ALIA DEF,EI NEFR SDR]
+∞
6.3
6
*
BBA50
NOMESCO Finland
Total parathyroidectomy
+∞
6.3
6
*
Q61.0
ICD-10 Finland
Congenital single renal cyst
+∞
6.3
6
*
5850B
ICD-9 Finland
Chronic renal failure[INSUFFICIENTIA RENIS CHRONICA CUM URAEMIA]
+∞
6.3
6
*
N04.9
ICD-10 Finland
Nephrotic syndrome, unspecified
27.3
6.3
8
*
GD1UN
NOMESCO Finland
Lung circulation SPECT
27.3
6.3
8
*
NHQ40
NOMESCO Finland
Amputation of toe
6.5
6.2
15
24
SPAT1099
SPAT
Measurement of blood pressure with Doppler ultrasound device
4.1
6.2
23
60
TPH20
NOMESCO Finland
Insertion of central venous catheter through subclavian or brachiocephalic vein
4.9
6.2
19
41
C10AX09
ATC
ezetimibe; oral
2.5
6.2
49
218
E0000UV
ATC
NA
1.9
6.1
121
788
FM1LE
NOMESCO Finland
Combined ultrasound and EKG examination of heart with tolerance test
12.9
6.1
10
8
SPAT1263
SPAT
Sampling
1.8
6.1
131
879
R02
ICPC
Shortness of breath/dyspnoea
2.5
6.1
48
213
ZXE11
NOMESCO Finland
Procedure duration 60 to 89 minutes
4.1
6.0
22
57

LabWAS

↥
OMOP Concept
People with measurements
Mean N measurements
Mean measured value
(ID) Name
N Cases
N Controls
OR
-log10(p)
cases
controls
unit
cases
controls
-log10(p)
N cases
N controls
(3020779) Urea [Moles/volume] in Serum or Plasma
244
254
31.48
240.78
26.7
7.2
mmol/l
17.1
10.9
19.84
237
240
(3000067) Parathyrin.intact [Mass/volume] in Serum or Plasma
214
214
25.29
212.90
13.4
3.9
ng/l
192.5
85.7
14.93
199
189
(3003458) Phosphate [Moles/volume] in Serum or Plasma
253
387
22.64
188.59
27.2
5.6
mmol/l
1.2
1.0
13.95
246
359
(3026493) Urate [Moles/volume] in Serum or Plasma
285
739
18.66
130.94
8.9
2.6
umol/l
3642.3
7060.9
0.56
277
632
(40763571) Iron/Transferrin [Ratio] in Serum or Plasma
216
421
12.33
124.94
10.0
2.4
%
22.4
22.8
0.15
201
367
(3002032) Base excess in Venous blood by calculation
176
279
12.00
119.76
14.3
4.0
mmol/l
1.1
1.7
1.14
153
220
(43055120) Cytomegalovirus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection
77
45
21.83
96.67
9.6
8.3
iu/ml
352.5
106.0
—
24
8
(3000991) Gas panel - Venous blood
148
252
9.63
92.26
15.3
9.4
—
—
—
0
0
(3007628) Bicarbonate [Moles/volume] standard in Venous blood
113
143
11.34
89.12
13.5
4.1
mmol/l
23.3
24.1
1.59
105
132
(3012336) Haptoglobin [Mass/volume] in Serum or Plasma
113
157
10.28
82.53
2.2
1.9
g/l
1.6
1.5
0.90
105
137
(3010566) Parathyrin.intact [Moles/volume] in Serum or Plasma
63
47
16.23
69.18
10.5
2.0
—
—
—
0
0
(3020427) Coagulation factor X inhibitor [Units/volume] in Platelet poor plasma by Coagulation assay
85
102
10.78
68.73
4.2
2.1
u/ml
0.4
0.4
0.12
47
49
(3050238) Crystals [Presence] in Synovial fluid by Light microscopy
70
67
12.90
66.12
1.8
1.3
—
—
—
0
0
(3020682) Albumin/Creatinine [Ratio] in Urine
250
943
7.24
65.67
10.3
3.8
mg/mmol
38.4
9.5
7.22
231
609
(3010130) Cytomegalovirus IgG Ab [Units/volume] in Serum or Plasma
56
38
17.45
64.55
2.7
1.5
u/ml
113.8
93.3
—
16
7
(3029287) Urinalysis microscopic panel [#/volume] - Urine by Automated count
262
1067
7.34
62.02
11.0
3.3
—
—
—
0
0
(3017918) Cytomegalovirus IgG Ab [Titer] in Serum or Plasma
58
46
15.00
61.31
2.5
1.5
—
—
—
0
0
(3042936) Bacteria identified in Isolate by Culture
160
430
6.14
60.57
3.2
2.0
—
—
—
0
0
(3022250) Lactate dehydrogenase [Enzymatic activity/volume] in Serum or Plasma by Lactate to pyruvate reaction
144
361
6.18
58.60
3.7
4.3
u/l
245.0
241.4
0.14
137
343
(3024561) Albumin [Mass/volume] in Serum or Plasma
280
1277
7.76
56.32
18.6
4.7
g/l
33.7
34.9
3.53
273
1190
(3023368) Bacteria identified in Blood by Culture
232
902
5.95
56.13
8.9
4.2
—
—
—
0
0
(3007080) Epstein Barr virus nuclear IgG Ab [Units/volume] in Serum
54
44
14.40
56.04
1.6
1.2
u/ml
325.7
319.6
0.02
43
23
(3002582) Erythrocytes [#/volume] in Urine
231
901
5.88
55.49
10.0
3.4
e6/l
36.0
129.1
0.71
219
702
(3001122) Ferritin [Mass/volume] in Serum or Plasma
252
1060
6.32
55.23
10.0
2.6
ug/l
281.9
163.5
8.02
246
965
(3009508) Creatinine [Moles/volume] in Urine
231
907
5.83
54.86
8.2
3.1
mmol/l
6.1
7.8
11.28
221
741
(40771025) 25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Moles/volume] in Serum or Plasma
249
1043
6.18
54.65
4.7
2.2
nmol/l
74.9
77.0
0.58
241
912
(3012516) Albumin [Mass/volume] in Urine
227
891
5.66
53.56
8.1
3.2
mg/l
198.3
201.0
0.01
200
596
(3007844) Epstein Barr virus capsid IgM Ab [Units/volume] in Serum by Immunoassay
53
46
13.46
52.87
1.6
1.2
—
—
—
0
0
(3000475) Leukocytes [#/volume] in Synovial fluid
60
65
10.99
51.67
1.9
1.6
e6/l
12582.9
11455.9
0.12
47
48
(3030467) Casts [#/volume] in Urine by Automated count
213
818
5.29
50.91
9.2
3.3
e6/l
0.3
0.6
1.60
192
614
(3019284) Hepatitis B virus surface Ag [Presence] in Serum
110
244
6.19
50.29
4.2
1.5
—
—
—
0
0
(43055554) Base excess.100% oxygenated [Moles/volume] standard in Capillary blood by calculation
102
216
6.32
48.86
9.2
3.3
mmol/l
1.5
1.7
0.16
67
161
(3027529) Toxoplasma gondii IgM Ab [Units/volume] in Serum
40
24
18.76
48.66
1.0
1.3
—
—
—
0
0
(3048929) Epstein Barr virus Ab [Presence] in Serum
56
60
10.98
48.51
1.6
1.2
—
—
—
0
0
(3000850) Epithelial cells [#/volume] in Urine
179
617
5.01
48.51
7.2
2.6
e6/l
4.2
4.0
0.07
169
536
(46235355) HIV 1 and 2 tests - Meaningful Use set
119
294
5.69
48.14
4.0
1.7
—
—
—
0
0
(3014959) Toxoplasma gondii IgG Ab [Units/volume] in Serum
40
25
18.00
47.68
2.0
2.5
—
—
—
0
0
(3016431) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Serum or Plasma
284
1429
6.99
47.47
39.5
6.8
mmol/l
1.2
1.2
0.51
256
1200
(3018095) Leukocytes [#/volume] in Urine
235
1015
5.26
47.38
11.5
4.0
e6/l
48.7
139.6
0.74
220
749
(3017143) Hepatitis C virus Ab [Presence] in Serum
105
238
5.94
46.60
4.4
1.5
—
—
—
0
0
(3009343) pH of Capillary blood
103
231
5.96
46.21
9.3
3.2
ph
7.4
7.4
0.18
23
16
(3007853) Bacteria identified in Skin by Aerobe culture
123
341
5.08
42.95
2.6
1.7
—
—
—
0
0
(3021901) Oxygen saturation in Capillary blood
53
63
9.78
42.38
4.0
2.1
—
—
—
0
0
(3020630) Protein [Mass/volume] in Serum or Plasma
105
258
5.44
42.22
3.1
2.7
g/l
63.1
66.1
2.86
97
235
(3029879) Epithelial cells.squamous [#/volume] in Urine by Automated count
150
496
4.62
41.75
7.2
3.1
e6/l
1.8
1.1
0.87
109
285
(3018418) pH of Serum or Plasma
203
847
4.47
41.10
22.1
4.1
ph
7.4
7.4
2.61
41
158
(1616796) Gas panel - Central venous blood
50
58
9.93
40.68
7.6
2.7
—
—
—
0
0
(3027945) Reticulocytes/100 erythrocytes in Blood
129
392
4.69
39.80
3.7
2.7
%
2.1
1.8
1.84
121
356
(3021197) Magnesium Ionized [Moles/volume] in Serum or Plasma
29
14
22.55
38.60
2.8
1.7
—
—
—
0
0
(3024928) Oxygen saturation in Venous blood
51
68
8.65
37.12
7.2
2.8
—
—
—
0
0
(3030306) Epithelial cells.non-squamous [#/volume] in Urine by Automated count
146
513
4.24
36.66
6.2
2.9
e6/l
0.8
1.0
0.28
106
300
(36304419) Bacteria [Presence] in Urine
185
771
4.07
36.37
8.5
3.3
—
—
—
0
0
(3023520) Reticulocytes [#/volume] in Blood
106
294
4.79
36.36
4.1
2.7
e9/l
72.3
69.6
0.27
82
234
(3051552) Clostridioides difficile toxin genes [Presence] in Stool by NAA with probe detection
87
206
5.33
36.07
2.5
1.6
—
—
—
0
0
(3021788) Differential panel - Synovial fluid
42
47
10.05
34.95
1.9
1.6
—
—
—
0
0
(3044938) Influenza virus A RNA [Presence] in Specimen by NAA with probe detection
143
512
4.09
34.66
2.9
1.8
—
—
—
0
0
(21492711) Cytomegalovirus IgG Ab avidity [Presence] in Serum or Plasma by Immunoassay
28
16
18.98
34.56
1.2
1.3
—
—
—
0
0
(3014148) Varicella zoster virus Ab [Titer] in Serum
28
16
18.98
34.56
1.1
1.1
—
—
—
0
0
(3021347) Calcium.ionized [Moles/volume] in Serum or Plasma
250
1313
4.42
34.51
30.3
6.1
mmol/l
1.2
1.2
1.47
241
1183
(40768446) Kidney Pathology biopsy report
40
9
50.15
33.61
2.1
1.6
—
—
—
0
0
(46236952) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (MDRD)
84
206
5.09
33.25
6.9
2.8
ml/min/173m2
26.2
64.8
26.19
58
93
(3015399) Transferrin receptor.soluble [Mass/volume] in Serum or Plasma
176
747
3.81
32.89
3.4
2.0
mg/l
3.4
3.1
0.87
162
648
(3001604) Monocytes [#/volume] in Blood
247
1318
4.20
32.54
11.4
5.7
e9/l
0.7
0.6
2.18
227
1131
(3006315) Basophils [#/volume] in Blood
247
1327
4.15
32.00
11.4
5.7
e9/l
0.0
0.0
0.72
227
1149
(3019309) Folate [Moles/volume] in Red Blood Cells
153
604
3.79
31.65
2.4
1.7
nmol/l
1172.9
1176.2
0.01
138
453
(42870588) Differential panel, method unspecified - Blood
197
923
3.70
31.19
10.7
5.6
—
—
—
0
0
(3047169) Lambda light chains.free [Mass/volume] in Serum or Plasma
59
111
6.22
31.17
2.4
3.8
mg/l
49.9
38.2
0.96
46
92
(3044941) Cell count panel - Synovial fluid
36
38
10.48
31.16
1.9
1.5
—
—
—
0
0
(3010144) Erythrocytes [#/volume] in Synovial fluid
30
24
13.61
31.02
1.5
1.1
e6/l
12461.8
181147.9
0.64
18
15
(3019198) Lymphocytes [#/volume] in Blood
248
1353
4.08
31.00
11.5
5.8
e9/l
1.6
1.9
2.45
228
1183
(3006184) Hemoglobin [Mass/volume] in Capillary blood
44
61
8.14
30.85
3.7
2.2
g/l
125.5
129.1
0.33
38
43
(3013115) Eosinophils [#/volume] in Blood
249
1373
4.04
30.37
11.9
5.9
e9/l
0.2
0.2
1.29
229
1203
(3034860) Kappa light chains.free [Mass/volume] in Serum
58
111
6.09
30.07
2.4
3.8
mg/l
75.6
121.9
0.38
44
91
(3012220) Varicella zoster virus IgM Ab [Presence] in Serum by Immunoassay
27
19
15.35
29.97
1.1
1.2
—
—
—
0
0
(3006504) Eosinophils/100 leukocytes in Blood
234
1255
3.77
29.39
12.2
5.8
%
3.1
2.9
0.42
229
1173
(3019902) Methicillin resistant Staphylococcus aureus [Presence] in Specimen by Organism specific culture
100
308
4.18
29.31
5.1
3.4
—
—
—
0
0
(3032080) INR in Blood by Coagulation assay
236
1282
3.75
28.85
28.0
9.7
inr
1.4
1.3
0.23
66
325
(3042733) HLA Ab [Presence] in Serum
32
5
70.34
28.46
7.6
7.8
—
—
—
0
0
(3002030) Lymphocytes/100 leukocytes in Blood
235
1288
3.67
27.99
12.3
6.0
%
20.6
25.9
13.20
229
1203
(3018010) Neutrophils/100 leukocytes in Blood
232
1265
3.63
27.79
11.6
5.8
%
63.5
58.5
9.28
226
1187
(3029187) Natriuretic peptide.B prohormone N-Terminal [Mass/volume] in Serum or Plasma
200
999
3.43
27.56
5.7
3.1
ng/l
7123.5
1663.0
8.05
190
868
(3013826) Glucose [Moles/volume] in Serum or Plasma
279
1723
4.45
27.44
12.7
4.9
mmol/l
7.9
6.9
5.99
272
1630
(40760888) Immunoglobulin light chains.free panel - Serum
47
80
6.66
27.31
1.4
4.6
—
—
—
0
0
(3026008) Bacteria identified in Urine by Culture
175
819
3.34
26.62
4.8
3.3
—
—
—
0
0
(3043924) Respiratory syncytial virus RNA [Identifier] in Specimen by NAA with probe detection
105
362
3.75
25.88
2.6
1.8
—
—
—
0
0
(3038288) Influenza virus B RNA [Presence] in Specimen by NAA with probe detection
105
363
3.74
25.76
2.6
1.9
—
—
—
0
0
(3013650) Neutrophils [#/volume] in Blood by Automated count
258
1547
3.77
25.68
14.1
9.1
e9/l
4.9
4.3
4.43
239
1355
(40767503) Oxygen content in Capillary blood by calculation
39
58
7.47
25.63
4.2
2.1
%
15.9
15.7
0.08
34
27
(3004588) Protein electrophoresis panel - Serum or Plasma
78
224
4.22
24.83
2.4
2.3
—
—
—
0
0
(3033658) Prothrombin time (PT) actual/Normal
156
711
3.21
24.31
8.1
4.1
%
86.6
84.0
0.42
151
700
(43054903) Holo-transcobalamin II [Moles/volume] in Serum
220
1222
3.27
24.29
2.9
2.1
pmol/l
94.5
92.6
0.22
135
659
(3037467) Urinalysis macro (dipstick) panel - Urine
288
1893
4.41
24.12
13.2
4.3
—
—
—
0
0
(3042602) Urea [Moles/volume] in Serum or Plasma --post dialysis
28
6
50.66
23.70
16.3
7.0
mmol/l
5.4
7.6
—
28
6
(3021952) Alkaline phosphatase isoenzymes [Enzymatic activity/volume] in Serum or Plasma by Heat stability
32
42
8.31
23.34
1.4
1.2
—
—
—
0
0
(3001467) Alkaline phosphatase.bone [Enzymatic activity/volume] in Serum or Plasma
25
24
11.16
22.94
1.3
1.1
u/l
73.6
53.9
0.48
16
16
(3037121) Protein [Mass/volume] in Urine
49
104
5.34
22.52
7.8
2.8
g/l
0.4
0.3
0.50
41
43
(3011648) Oxygen content in Venous blood
24
23
11.15
22.02
4.4
2.1
%
10.1
11.1
0.43
24
23
(3044640) Blood type and Crossmatch panel - Blood
179
921
2.99
21.95
4.7
2.7
—
—
—
0
0
(36305247) Microscopic observation [Identifier] in Isolate by Gram stain
41
76
6.00
21.77
2.5
1.4
—
—
—
0
0
(3022313) Gas panel - Capillary blood
64
174
4.30
21.75
10.8
3.4
—
—
—
0
0
(3004383) Neutrophil cytoplasmic Ab.classic [Titer] in Serum by Immunofluorescence
33
49
7.35
21.64
1.5
1.1
—
—
—
0
0
(3015377) Calcium [Moles/volume] in Serum or Plasma
180
936
2.96
21.53
6.7
3.4
mmol/l
2.3
2.3
0.00
169
807
(3019832) Treponema pallidum Ab [Presence] in Serum
45
93
5.42
21.27
3.0
1.6
—
—
—
0
0
(3008909) Norovirus RNA [Presence] in Stool by NAA with probe detection
43
86
5.58
21.06
2.0
1.2
—
—
—
0
0
(3019230) Fractional oxyhemoglobin in Venous blood
33
51
7.06
20.86
8.2
2.1
%
72.2
63.3
1.12
33
51
(3017181) Myelocytes/100 leukocytes in Blood
73
225
3.86
20.84
6.3
4.2
%
1.0
0.8
0.38
35
77
(3027946) Carbon dioxide [Partial pressure] in Arterial blood
99
373
3.33
20.77
6.9
7.5
kpa
5.0
5.1
0.32
92
355
(3015736) pH of Urine
186
998
2.91
20.77
7.2
3.6
—
—
—
0
0
(3021440) Promyelocytes/100 leukocytes in Blood
70
210
3.94
20.76
6.4
4.2
%
0.1
0.1
0.30
34
69
(3027801) Oxygen [Partial pressure] in Arterial blood
99
374
3.32
20.67
6.9
7.5
kpa
10.6
11.4
1.12
90
358
(3003396) Base excess in Arterial blood by calculation
98
369
3.33
20.56
7.0
7.6
mmol/l
-0.1
1.0
1.19
74
301
(3001079) Blood group antibody screen [Presence] in Serum or Plasma
217
1271
2.96
20.43
6.7
4.2
—
—
—
0
0
(3002179) Metamyelocytes/100 leukocytes in Blood
67
197
3.99
20.42
5.5
4.0
%
0.7
0.4
1.39
27
56
(3006571) Polymorphonuclear cells/100 leukocytes in Synovial fluid
26
31
9.00
20.40
1.5
1.3
%
68.3
64.6
0.17
20
24
(3024471) HLA-A [Type]
25
7
38.38
20.12
1.0
1.0
—
—
—
0
0
(3024932) HLA-DR beta [Type]
25
7
38.38
20.12
1.0
1.3
—
—
—
0
0
(46236098) ABO and Rh group [Type] in Blood by Confirmatory method
143
685
2.88
19.49
4.3
2.7
—
—
—
0
0
(3035350) Ketones [Presence] in Urine by Test strip
217
1291
2.88
19.48
9.1
3.7
estimate
0.0
0.0
0.00
48
240
(3016502) Oxygen saturation in Arterial blood
91
339
3.30
19.31
7.3
7.8
%
94.0
95.0
0.50
85
328
(3025159) Blasts/100 leukocytes in Blood
65
196
3.86
19.05
6.1
4.2
%
0.0
0.2
0.87
29
60
(3009261) Glucose [Presence] in Urine by Test strip
217
1305
2.83
18.83
9.2
3.8
estimate
0.0
0.0
0.00
50
227
(3003434) Protein [Mass/volume] in Pleural fluid
29
44
7.11
18.60
1.5
1.3
g/l
22.6
27.9
1.11
24
39
(3022217) INR in Platelet poor plasma by Coagulation assay
107
452
3.00
18.19
41.6
25.4
inr
1.8
1.3
1.18
13
58
(3043747) Beta 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis
50
129
4.37
18.07
2.7
1.8
g/l
3.7
3.7
0.08
38
94
(3043723) Beta 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis
50
129
4.37
18.07
2.7
1.8
—
—
—
0
0
(3005229) Alpha 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis
50
129
4.37
18.07
2.7
1.8
g/l
7.7
7.3
0.91
38
99
(3021601) Nitrite [Presence] in Urine by Test strip
213
1289
2.75
17.91
13.1
5.1
estimate
0.0
0.0
0.00
52
242
(3035995) Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma
296
2145
3.94
17.83
21.5
7.8
u/l
93.0
79.2
2.37
289
2005
(3037522) Nuclear Ab [Titer] in Serum
81
296
3.28
17.61
1.7
1.3
titre
386.7
357.7
0.14
18
69
(3003329) Lymphocytes/100 leukocytes in Synovial fluid
21
23
9.67
17.49
1.4
1.3
%
20.5
30.0
0.57
16
17
(3042194) Human metapneumovirus RNA [Presence] in Specimen by NAA with probe detection
34
65
5.70
17.41
2.3
1.6
—
—
—
0
0
(3021589) Normoblasts [#/volume] in Blood
197
1160
2.66
17.30
26.4
9.5
e9/l
0.0
0.0
0.03
166
944
(3024403) Complement+Immunoglobulin [Units/volume] in Red Blood Cells
38
83
5.03
16.79
1.5
1.6
—
—
—
0
0
(3041942) Cyclic citrullinated peptide Ab [Units/volume] in Serum
89
354
3.05
16.68
1.3
1.3
u/ml
10.0
10.8
0.03
28
140
(40765161) Human bocavirus DNA [Presence] in Specimen by NAA with probe detection
28
46
6.54
16.66
2.4
1.7
—
—
—
0
0
(3050449) Albumin [Mass/time] in Urine collected for unspecified duration
38
84
4.97
16.56
3.6
2.2
ug/min
144.4
92.1
0.39
26
45
(3018921) Toxoplasma gondii IgA Ab [Units/volume] in Serum
20
5
42.37
16.51
1.0
1.0
—
—
—
0
0
(3021879) Hepatitis B virus core Ab [Presence] in Serum
53
153
3.92
16.43
2.6
1.4
—
—
—
0
0
(40762485) Glomerular basement membrane Ab [Units/volume] in Serum by Immunoassay
23
31
7.89
16.30
1.1
1.1
—
—
—
0
0
(3016750) Collection duration of Urine
18
18
10.50
15.94
3.8
2.2
min
531.1
504.5
—
18
10
(3040853) Adenovirus DNA [Identifier] in Specimen by NAA with probe detection
33
67
5.35
15.81
2.3
1.6
—
—
—
0
0
(586526) SARS-CoV-2 (COVID-19) RNA [Presence] in Nasopharynx by NAA with probe detection
59
191
3.53
15.43
2.0
1.4
—
—
—
0
0
(40760109) Toxoplasma gondii IgG Ab avidity [Ratio] in Serum by Immunoassay
20
7
30.22
15.36
1.0
1.0
—
—
—
0
0
(3012501) Base excess in Blood by calculation
31
61
5.49
15.36
7.1
3.1
mmol/l
2.0
2.2
0.16
16
37
(40758558) Short blood count panel - Blood
132
670
2.59
15.33
12.6
6.8
—
—
—
0
0
(3042596) Human coronavirus RNA [Presence] in Specimen by NAA with probe detection
21
29
7.65
14.56
1.6
1.4
—
—
—
0
0
(3015322) Alpha 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis
44
121
4.03
14.53
2.9
1.8
g/l
3.2
3.2
0.09
38
95
(3002173) Hemoglobin [Mass/volume] in Arterial blood
76
300
2.97
14.26
8.1
8.4
g/l
114.1
120.3
1.46
71
293
(3019800) Troponin T.cardiac [Mass/volume] in Serum or Plasma
193
1202
2.40
13.95
6.8
4.0
ng/l
137.0
54.5
1.14
170
924
(40760892) CBC W Ordered Manual Differential panel - Blood
108
520
2.58
13.77
8.1
5.2
—
—
—
0
0
(3013527) Hepatitis B virus core IgM Ab [Presence] in Serum
23
38
6.42
13.57
1.6
1.2
—
—
—
0
0
(3045788) Cell count panel - Pleural fluid
21
32
6.93
13.35
1.2
1.2
—
—
—
0
0
(3021614) Rheumatoid factor [Units/volume] in Serum or Plasma
86
375
2.73
13.34
1.4
1.2
iu/ml
31.6
33.8
0.08
30
115
(46237023) Hepatitis B virus core and surface Ab and surface Ag panel - Serum
30
66
4.89
13.10
2.4
1.4
—
—
—
0
0
(3021337) Troponin I.cardiac [Mass/volume] in Serum or Plasma
116
591
2.46
13.00
7.7
3.9
ng/l
75.2
324.4
2.19
107
498
(3021960) Folate [Moles/volume] in Serum or Plasma
139
769
2.37
12.94
2.2
1.6
nmol/l
19.5
20.3
0.20
132
651
(3025941) Bacteria identified in Stool by Culture
43
127
3.73
12.82
1.5
1.3
—
—
—
0
0
(3014218) Bicarbonate [Moles/volume] standard in Arterial blood
52
176
3.31
12.59
6.2
10.5
mmol/l
23.0
24.4
1.73
46
166
(3005895) Myoglobin [Mass/volume] in Serum or Plasma
41
119
3.78
12.53
2.4
2.3
ug/l
272.6
721.0
0.65
41
113
(3030692) Respiratory virus DNA+RNA [Identifier] in Specimen by NAA with probe detection
22
38
6.12
12.43
1.9
1.4
—
—
—
0
0
(3011397) Hemoglobin [Presence] in Urine by Test strip
113
581
2.42
12.31
6.3
3.8
—
—
—
0
0
(3036489) Thrombin time
36
97
4.03
12.19
2.2
2.1
s
24.0
21.9
1.25
31
91
(40769539) Bacteria identified based on 16S rRNA gene [Identifier] in Specimen by Sequencing
28
62
4.83
12.13
1.6
1.6
—
—
—
0
0
(3002434) Lupus erythematosus deoxynucleoproteins IgG Ab [Units/volume] in Serum by Immunoassay
29
67
4.64
11.94
3.0
1.6
—
—
—
0
0
(3013707) Erythrocyte sedimentation rate by Westergren method
264
1960
2.55
11.92
7.4
4.2
mm/h
30.4
13.2
19.80
253
1784
(3051714) Fibrin D-dimer FEU [Mass/volume] in Platelet poor plasma
111
575
2.38
11.82
2.8
1.7
mg/l
1.4
1.5
0.07
91
448
(3035062) Alkaline phosphatase.liver 1 [Enzymatic activity/volume] in Serum or Plasma
14
15
9.69
11.73
1.2
1.2
u/l
73.8
111.1
—
14
10
(36031861) Influenza virus A and B and SARS-CoV-2 (COVID-19) and Respiratory syncytial virus RNA panel - Respiratory system specimen by NAA with probe detection
55
201
3.07
11.70
2.3
1.7
—
—
—
0
0
(3033705) Calcium.ionized [Moles/volume] in Venous blood
23
45
5.41
11.43
6.0
3.5
—
—
—
0
0
(3034780) Angiotensin converting enzyme [Enzymatic activity/volume] in Serum or Plasma
39
117
3.64
11.34
2.9
2.1
u/l
41.5
39.2
0.31
34
103
(3020013) Alkaline phosphatase.intestinal [Enzymatic activity/volume] in Serum or Plasma
14
16
9.08
11.19
1.5
1.5
u/l
5.1
23.9
—
8
9
(3043362) Influenza virus B Ag [Presence] in Nasopharynx by Immunoassay
27
64
4.50
10.77
1.6
1.4
—
—
—
0
0
(3046524) Influenza virus A Ag [Presence] in Nasopharynx by Immunoassay
27
64
4.50
10.77
1.6
1.4
—
—
—
0
0
(3013721) Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma
147
885
2.16
10.69
4.2
3.4
u/l
50.4
33.8
0.60
142
844
(3002482) Mycoplasma pneumoniae DNA [Presence] in Specimen by NAA with probe detection
25
56
4.74
10.67
1.6
1.5
—
—
—
0
0
(3031478) Chlamydophila pneumoniae DNA [Presence] in Specimen by NAA with probe detection
22
46
5.04
10.16
1.4
1.5
—
—
—
0
0
(3012441) Differential panel - Pleural fluid
19
36
5.53
9.75
1.4
1.2
—
—
—
0
0
(3000330) Specific gravity of Urine by Test strip
43
151
3.12
9.74
12.2
4.3
—
—
—
0
0
(3012477) Bordetella pertussis DNA [Presence] in Specimen by NAA with probe detection
22
48
4.83
9.67
1.6
1.5
—
—
—
0
0
(3020565) Legionella pneumophila DNA [Presence] in Specimen by NAA with probe detection
20
41
5.12
9.43
1.6
1.5
—
—
—
0
0
(3028369) Herpes simplex virus 1+2 DNA [Presence] in Specimen by NAA with probe detection
15
23
6.78
9.43
1.5
1.6
—
—
—
0
0
(3037756) Immunofixation for Serum or Plasma
29
81
3.82
9.33
1.1
1.6
—
—
—
0
0
(1761482) Bacteria [#/volume] in Urine by Culture
32
96
3.58
9.29
6.2
5.4
—
—
—
0
0
(3028026) IgM [Mass/volume] in Serum or Plasma
43
156
3.01
9.21
1.7
1.6
g/l
0.9
1.7
1.12
43
142
(3011391) Calcitriol [Moles/volume] in Serum or Plasma
14
21
6.91
8.96
1.3
1.3
—
—
—
0
0
(3019060) Gas panel - Arterial blood
54
225
2.66
8.95
5.9
4.2
—
—
—
0
0
(3004410) Hemoglobin A1c/Hemoglobin.total in Blood
301
2504
2.76
8.64
14.4
6.4
mmol/mol
45.0
41.0
6.06
295
2301
(44790048)
17
33
5.37
8.49
2.0
1.7
—
—
—
0
0
(44790049)
17
33
5.37
8.49
2.0
1.7
—
—
—
0
0
(44790047)
17
33
5.37
8.49
2.0
1.7
—
—
—
0
0
(44806118)
17
33
5.37
8.49
2.0
1.7
—
—
—
0
0
(40761535) Cells panel - Urine sediment
54
231
2.59
8.48
9.7
3.5
—
—
—
0
0
(40768806) Pleura Pathology biopsy report
18
37
5.08
8.46
1.5
1.3
—
—
—
0
0
(40762366) Oxygen capacity [Volume Fraction] in Arterial blood
45
178
2.76
8.23
9.2
9.6
—
—
—
0
0
(21494890) Protein electrophoresis panel - 24 hour Urine
17
34
5.21
8.23
1.2
2.9
—
—
—
0
0
(3035880) pH of Pleural fluid
13
20
6.72
8.12
1.2
1.2
—
—
—
0
0
(3023601) Vancomycin resistant enterococcus [Presence] in Specimen by Organism specific culture
15
27
5.77
8.09
4.2
2.2
—
—
—
0
0
(3008486) Thyroxine (T4) free [Moles/volume] in Serum or Plasma
240
1843
2.03
8.03
4.4
3.6
pmol/l
14.8
15.0
0.72
228
1631
(3008152) Bicarbonate [Moles/volume] in Arterial blood
48
200
2.63
7.93
9.4
6.1
mmol/l
23.8
24.3
0.37
42
187
(3020460) C reactive protein [Mass/volume] in Serum or Plasma
309
2642
2.86
7.69
63.6
16.2
mg/l
28.5
27.1
0.37
301
2161
(3016417) Amylase.pancreatic [Enzymatic activity/volume] in Serum or Plasma
57
262
2.41
7.67
4.7
2.5
u/l
44.8
36.5
0.70
52
222
(3024263) Appearance of Synovial fluid
11
15
7.55
7.59
1.5
1.8
—
—
—
0
0
(37019628) Gastrointestinal bacterial pathogens panel - Stool by NAA with probe detection
21
54
4.08
7.55
2.4
1.4
—
—
—
0
0
(3041096) Erythrocytes [Presence] in Urine by Automated
118
728
1.95
7.47
10.4
3.4
—
—
—
0
0
(3052851) Hemolysis interference index of Serum or Plasma
29
95
3.24
7.35
7.0
3.4
—
—
—
0
0
(3003327) Ova and parasites identified in Stool by Light microscopy
21
56
3.93
7.19
1.8
1.5
—
—
—
0
0
(40763086) Leukocyte esterase [Presence] in Urine by Automated test strip
149
1002
1.87
7.19
10.5
4.0
—
—
—
0
0
(3025315) Body weight
10
5
20.54
7.17
6.2
3.4
—
—
—
0
0
(3014162) Mycobacterium tuberculosis DNA [Presence] in Specimen by NAA with probe detection
33
120
2.94
7.03
2.9
3.2
—
—
—
0
0
(3048773) Triglyceride [Moles/volume] in Serum or Plasma --fasting
294
2484
2.36
7.01
7.6
4.3
mmol/l
1.7
1.3
10.04
282
2244
(40764126) Parainfluenza virus RNA [Presence] in Specimen by NAA with probe detection
12
20
6.18
6.95
1.8
1.3
—
—
—
0
0
(4035726)
54
256
2.32
6.75
1.7
1.4
—
—
—
0
0
(3013512) EKG study
135
897
1.84
6.65
7.5
4.4
—
—
—
0
0
(3009542) Hematocrit [Volume Fraction] of Blood
276
2295
2.08
6.53
56.3
17.9
%
34.0
39.5
10.07
176
1515
(3000093) Morphology [Interpretation] in Blood Narrative
15
33
4.71
6.52
1.1
1.2
—
—
—
0
0
(3020059) Calcium [Moles/volume] corrected for albumin in Serum or Plasma
94
560
1.94
6.46
3.5
3.2
mmol/l
2.5
2.5
3.38
83
487
(3030905) Polymorphonuclear cells [#/volume] in Blood
17
42
4.21
6.43
4.8
2.3
e9/l
3.7
4.9
1.34
17
42
(3024891) Influenza virus A+B Ag [Presence] in Specimen
22
66
3.49
6.39
1.5
1.3
—
—
—
0
0
(3013742) Prealbumin [Mass/volume] in Serum or Plasma
56
276
2.23
6.39
2.8
2.4
g/l
0.2
0.2
1.44
51
257
(46235759) Influenza virus B RNA [Presence] in Nasopharynx by NAA with probe detection
33
127
2.77
6.35
3.3
1.7
—
—
—
0
0
(3044927) Protein electrophoresis panel - Urine
15
34
4.57
6.30
1.7
1.1
—
—
—
0
0
(3009035) Cobalamin (Vitamin B12) [Moles/volume] in Serum or Plasma
102
630
1.88
6.27
1.9
1.9
pmol/l
479.7
7812930.2
0.50
93
512
(40763091) Bacteria identified in Peritoneal dialysis fluid by Culture
6
0
+∞
6.27
4.2
0.0
—
—
—
0
0
(3000570) Elastase.pancreatic [Mass/mass] in Stool
22
68
3.39
6.11
1.8
1.5
ug/g
266.1
264.1
0.02
17
43
(3044355) Beta 2 glycoprotein 1 IgG Ab [Units/volume] in Serum or Plasma by Immunoassay
15
35
4.44
6.09
1.3
1.3
u/ml
2.9
1.9
—
9
13
(3045424) Erythrocytes [Presence] in Urine
17
44
4.01
6.06
2.1
1.4
—
—
—
0
0
(3044254) Respiratory syncytial virus RNA [Presence] in Specimen by NAA with probe detection
30
114
2.79
5.91
2.4
1.6
—
—
—
0
0
(3032035) Polymorphonuclear cells/100 leukocytes in Blood
17
45
3.92
5.89
6.1
2.8
%
56.2
59.6
0.54
17
45
(3023602) Cholesterol in HDL [Moles/volume] in Serum or Plasma
297
2569
2.23
5.87
8.0
4.7
mmol/l
1.2
1.4
10.54
285
2332
(3045414) Leukocytes [Presence] in Urine
29
110
2.79
5.73
4.1
1.8
—
—
—
0
0
(3019900) Cholesterol [Moles/volume] in Serum or Plasma
298
2588
2.23
5.72
8.1
4.8
mmol/l
4.0
4.4
9.40
287
2365
(37020957) Sapovirus genogroups I+II+IV+V RNA [Presence] in Stool by NAA with probe detection
11
21
5.38
5.56
2.3
1.2
—
—
—
0
0
(42869457) Rotavirus RNA [Identifier] in Stool by NAA with probe detection
11
21
5.38
5.56
2.3
1.2
—
—
—
0
0
(3007164) IgA [Mass/volume] in Serum or Plasma
75
434
1.93
5.55
1.6
1.4
g/l
2.9
2.8
0.06
59
268
(3003694) ABO and Rh group [Type] in Blood
105
678
1.79
5.50
1.4
1.3
—
—
—
0
0
(3016251) Hemoglobin.gastrointestinal [Presence] in Stool
32
132
2.57
5.39
3.2
2.6
—
—
—
0
0
(3044889) 12 lead EKG panel
237
1929
1.75
5.29
6.1
4.2
—
—
—
0
0
(3029937) Albumin [Presence] in Urine by Test strip
108
711
1.76
5.26
9.9
3.9
estimate
0.0
0.0
0.50
42
232
(42868716) Shigella species+EIEC invasion plasmid antigen H ipaH gene [Presence] in Stool by NAA with probe detection
14
35
4.13
5.22
2.6
1.4
—
—
—
0
0
(40768804) Tissue Pathology biopsy report
144
1031
1.69
5.16
3.0
2.2
—
—
—
0
0
(3005702) Mycobacterium sp identified in Specimen by Organism specific culture
21
71
3.09
5.08
1.5
1.4
—
—
—
0
0
(3001308) Cholesterol in LDL [Moles/volume] in Serum or Plasma
301
2654
2.17
5.07
8.5
5.3
mmol/l
2.1
2.6
16.74
290
2409
(3025468) Yersinia sp identified in Specimen by Organism specific culture
14
36
4.01
5.04
2.6
1.4
—
—
—
0
0
(3024522) Salmonella sp identified in Specimen by Organism specific culture
14
36
4.01
5.04
2.5
1.4
—
—
—
0
0
(3012568) Campylobacter sp identified in Specimen by Organism specific culture
14
36
4.01
5.04
2.6
1.4
—
—
—
0
0
(21493466) Plesiomonas shigelloides DNA [Presence] in Stool by NAA with non-probe detection
14
36
4.01
5.04
2.6
1.4
—
—
—
0
0
(3040359) Human coronavirus NL63 RNA [Presence] in Specimen by NAA with probe detection
12
28
4.41
4.86
3.1
1.9
—
—
—
0
0
(3038546) Human coronavirus OC43 RNA [Presence] in Specimen by NAA with probe detection
12
28
4.41
4.86
3.1
1.9
—
—
—
0
0
(3041642) Human coronavirus 229E RNA [Presence] in Specimen by NAA with probe detection
12
28
4.41
4.86
3.1
1.9
—
—
—
0
0
(3005988) Vibrio sp identified in Specimen by Organism specific culture
14
37
3.90
4.86
2.6
1.4
—
—
—
0
0
(3008757) Leukocyte morphology finding [Identifier] in Blood
15
42
3.69
4.82
4.1
3.9
—
—
—
0
0
(3022689) Creatine [Moles/volume] in Urine
8
7
11.66
4.81
2.8
1.6
—
—
—
0
0
(3009201) Thyrotropin [Units/volume] in Serum or Plasma
272
2331
1.83
4.79
5.9
4.4
mu/l
2.4
2.0
3.30
258
2085
(3049717) Cytology report of Urine Cyto stain
34
153
2.36
4.78
2.6
2.8
—
—
—
0
0
(706163) SARS-CoV-2 (COVID-19) RNA [Presence] in Respiratory system specimen by NAA with probe detection
175
1336
1.64
4.78
3.3
2.3
—
—
—
0
0
(3023150) Myeloperoxidase Ab [Units/volume] in Serum
15
43
3.60
4.67
1.2
1.3
—
—
—
0
0
(3009595) Pneumocystis jiroveci DNA [Presence] in Specimen by NAA with probe detection
12
29
4.25
4.66
2.1
1.6
—
—
—
0
0
(3000494) Fungus identified in Specimen by Culture
60
341
1.92
4.64
2.1
1.4
—
—
—
0
0
(3022575) Varicella zoster virus IgG Ab [Units/volume] in Serum
7
5
14.25
4.59
1.0
1.0
miu/ml
1616.0
1392.0
—
7
5
(3025023) Rhinovirus RNA [Presence] in Specimen by NAA with probe detection
12
30
4.11
4.47
2.6
1.9
—
—
—
0
0
(3006418) Campylobacter sp identified in Tissue by Organism specific culture
20
72
2.89
4.36
1.5
1.2
—
—
—
0
0
(42529406) Shigella sp [Presence] in Stool by Culture
20
73
2.85
4.26
1.5
1.2
—
—
—
0
0
(3014765) Yersinia sp identified in Stool by Organism specific culture
20
73
2.85
4.26
1.5
1.2
—
—
—
0
0
(40761511) CBC panel - Blood by Automated count
304
2734
2.06
4.16
59.1
15.3
—
—
—
0
0
(3022192) Triglyceride [Mass/volume] in Serum or Plasma
7
7
10.18
4.02
5.7
3.7
—
—
—
0
0
(3004716) Salmonella sp identified in Stool by Organism specific culture
24
100
2.51
3.99
1.6
1.3
—
—
—
0
0
(40768443) Skin Pathology biopsy report
26
113
2.41
3.96
1.4
1.2
—
—
—
0
0
(3016881) Enterovirus RNA [Presence] in Specimen by NAA with probe detection
12
33
3.73
3.95
2.6
1.8
—
—
—
0
0
(3048689) Calprotectin [Mass/mass] in Stool
43
232
1.98
3.86
1.5
2.3
ug/g
280.2
158.3
0.48
38
188
(3026910) Gamma glutamyl transferase [Enzymatic activity/volume] in Serum or Plasma
204
1669
1.56
3.80
5.7
3.3
u/l
88.0
53.3
1.94
196
1542
(40768797) Stomach Pathology biopsy report
60
363
1.79
3.80
1.2
1.3
—
—
—
0
0
(3009041) Cardiolipin IgG Ab [Units/volume] in Serum by Immunoassay
13
39
3.43
3.80
1.5
1.3
u/ml
1.8
7.9
—
6
22
(3020564) Creatinine [Moles/volume] in Serum or Plasma
308
2812
2.01
3.58
72.9
19.5
umol/l
222.5
84.6
40.89
308
2812
(37020937) Giardia lamblia DNA [Presence] in Stool by NAA with probe detection
8
13
6.27
3.52
1.3
1.1
—
—
—
0
0
(36305771) Cryptosporidium sp DNA [Presence] in Stool by NAA with probe detection
8
13
6.27
3.52
1.3
1.1
—
—
—
0
0
(4306422)
11
31
3.63
3.51
1.2
1.3
—
—
—
0
0
(3036669) Protein S actual/normal in Platelet poor plasma by Coagulation assay
6
6
10.15
3.51
1.0
1.2
%
96.8
106.7
—
6
6
(42868544) Hantavirus puumala IgM Ab [Presence] in Serum or Plasma by Immunofluorescence
14
47
3.06
3.45
1.1
1.1
—
—
—
0
0
(3032699) Streptococcus pneumoniae DNA [Presence] in Specimen by NAA with probe detection
9
18
5.10
3.39
1.4
1.3
—
—
—
0
0
(3013727) Leukocytes other/100 leukocytes in Blood
7
10
7.12
3.38
3.9
5.4
%
61.8
44.8
—
7
10
(3015816) F5 gene p.Arg506Gln [Presence] in Blood or Tissue by Molecular genetics method
11
32
3.52
3.36
1.2
1.2
—
—
—
0
0
(3002256) Pathology report gross observation
60
377
1.72
3.33
1.5
1.3
—
—
—
0
0
(3019050) Tissue transglutaminase IgA Ab [Units/volume] in Serum
71
469
1.65
3.27
1.3
1.2
u/ml
0.8
1.2
0.97
17
126
(3001964) Herpes simplex virus Ag [Presence] in Specimen
6
7
8.70
3.27
1.0
1.4
—
—
—
0
0
(3048821) Cortisol [Moles/volume] in Serum or Plasma --post 1 mg dexamethasone PO overnight
10
28
3.65
3.22
1.1
1.3
—
—
—
0
0
(37020445) Astrovirus RNA [Presence] in Stool by NAA with probe detection
9
20
4.59
3.13
2.6
1.3
—
—
—
0
0
(3011363) Streptococcus pneumoniae Ag [Presence] in Urine
9
20
4.59
3.13
1.0
1.1
—
—
—
0
0
(37021247) Adenovirus 40+41 DNA [Presence] in Stool by NAA with probe detection
9
20
4.59
3.13
2.6
1.3
—
—
—
0
0
(3029080) Hemoglobin [Entitic mass] in Reticulocytes
12
39
3.15
3.12
2.3
2.0
pg
33.0
32.9
0.02
12
39
(4268621)
10
29
3.52
3.07
1.9
2.4
—
—
—
0
0
(3025634) Parainfluenza virus 1 RNA [Presence] in Specimen by NAA with probe detection
7
12
5.93
3.03
3.0
2.0
—
—
—
0
0
(3038297) Parainfluenza virus 4 RNA [Presence] in Specimen by NAA with probe detection
7
12
5.93
3.03
2.9
2.0
—
—
—
0
0
(3012158) Parainfluenza virus 2 RNA [Presence] in Specimen by NAA with probe detection
7
12
5.93
3.03
3.0
2.0
—
—
—
0
0
(3006262) Parainfluenza virus 3 RNA [Presence] in Specimen by NAA with probe detection
7
12
5.93
3.03
3.0
2.0
—
—
—
0
0
(40764999) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI)
280
2517
1.64
3.02
57.7
15.2
ml/min/173m2
34.6
75.8
96.89
264
2099
(3012202) Varicella zoster virus DNA [Presence] in Specimen by NAA with probe detection
9
21
4.37
3.01
1.0
1.3
—
—
—
0
0
(3019601) Blood group antibody investigation [Interpretation] in Plasma or RBC
8
17
4.79
2.93
1.4
1.1
—
—
—
0
0
(3019225) pH of Specimen
48
294
1.74
2.92
26.5
4.2
—
—
—
0
0
(3005757) Coagulation factor V activity actual/normal in Platelet poor plasma by Coagulation assay
7
13
5.47
2.88
4.0
1.9
%
100.4
99.2
—
7
13
(3037875) Bordetella parapertussis DNA [Presence] in Specimen by NAA with probe detection
7
13
5.47
2.88
1.6
1.3
—
—
—
0
0
(3036086) Jo-1 extractable nuclear Ab [Units/volume] in Serum by Immunoassay
14
53
2.71
2.83
1.1
1.2
—
—
—
0
0
(3038071) Oxygen [Partial pressure] in Mixed venous blood
5
7
7.23
2.55
18.4
8.1
—
—
—
0
0
(3021513) Carbon dioxide [Partial pressure] in Mixed venous blood
5
7
7.23
2.55
18.2
8.0
—
—
—
0
0
(3005156) Respiratory syncytial virus A RNA [Presence] in Specimen by NAA with probe detection
6
11
5.53
2.55
3.0
2.1
—
—
—
0
0
(3000108) Respiratory syncytial virus B RNA [Presence] in Specimen by NAA with probe detection
6
11
5.53
2.55
3.0
2.1
—
—
—
0
0
(40761536) Microorganisms panel - Urine sediment
36
213
1.77
2.48
15.6
3.4
—
—
—
0
0
(3014271) Vancomycin [Susceptibility]
8
21
3.87
2.48
2.9
2.5
—
—
—
0
0
(3017704) Immunofixation for Urine
8
21
3.87
2.48
1.3
1.9
—
—
—
0
0
(3022145) Colonoscopy Study observation
45
284
1.67
2.47
1.4
1.3
—
—
—
0
0
(40764127) Haemophilus influenzae DNA [Presence] in Specimen by NAA with probe detection
6
12
5.07
2.41
1.7
1.3
—
—
—
0
0
(21493195) Respiratory pathogens DNA and RNA tested for in Respiratory system specimen by NAA with probe detection
6
12
5.07
2.41
3.2
2.0
—
—
—
0
0
(3042631) Mycobacterium sp identified in Specimen
11
40
2.81
2.39
1.5
3.2
—
—
—
0
0
(3019150) Specific gravity of Urine by Refractometry
78
565
1.49
2.39
8.1
4.2
kg/l
1.0
1.0
—
9
86
(3020229) Cytomegalovirus DNA [Presence] in Specimen by NAA with probe detection
5
8
6.32
2.38
1.2
1.3
—
—
—
0
0
(3022621) pH of Urine by Test strip
31
178
1.82
2.36
6.7
2.9
—
—
—
0
0
(21493690) Lymphocyte T-cell and B-cell and Natural killer subsets panel - Blood
6
13
4.68
2.28
1.5
2.0
—
—
—
0
0
(44806420)
6
13
4.68
2.28
2.7
2.2
—
—
—
0
0
(3020891) Body temperature
22
114
1.99
2.26
15.8
4.1
—
—
—
0
0
(3047189) Immunofixation for 24 hour Urine
6
14
4.34
2.16
1.0
1.4
—
—
—
0
0
(4010399)
32
202
1.64
1.79
1.4
1.5
—
—
—
0
0
(3034770) Mitochondria Ab [Titer] in Serum
14
67
2.14
1.78
1.3
1.2
titre
—
—
—
0
0
(43055361) Metamyelocytes/Leukocytes [Pure number fraction] in Blood by Manual count
6
18
3.37
1.75
6.3
4.4
—
—
—
0
0
(3003785) Carcinoembryonic Ag [Mass/volume] in Serum or Plasma
46
319
1.51
1.74
2.5
4.4
ug/l
3.9
47.5
1.08
40
268
(3051651) Icteric interference index of Serum or Plasma
7
25
2.84
1.66
11.4
3.2
—
—
—
0
0
(3004616) Nuclear Ab [Presence] in Serum
7
25
2.84
1.66
1.1
1.2
—
—
—
0
0
(3007821) Glucose [Moles/volume] in Serum or Plasma --baseline
5
14
3.61
1.62
1.0
1.2
mmol/l
6.0
7.8
—
5
14
(3007847) Interleukin 2 Receptor Soluble [Units/volume] in Serum or Plasma
5
14
3.61
1.62
4.2
1.6
u/ml
1370.4
1144.2
—
5
14
(3048879) Bone marrow aspiration report
5
15
3.37
1.53
2.8
2.3
—
—
—
0
0
(46235128) Lupus anticoagulant aPTT and dRVVT screening panel W Reflex
5
15
3.37
1.53
1.6
1.1
—
—
—
0
0
(3016888) Borrelia burgdorferi IgG Ab [Units/volume] in Serum
23
139
1.70
1.52
1.1
1.3
—
45.1
—
0
12
(4062490)
7
27
2.63
1.52
1.4
1.3
—
—
—
0
0
(3012447) Hantavirus puumala IgG Ab [Titer] in Serum
7
28
2.53
1.46
1.1
1.1
—
—
—
0
0
(3014791) Apolipoprotein B [Mass/volume] in Serum or Plasma
5
16
3.16
1.44
2.8
1.5
g/l
1.0
1.0
—
5
16
(3000012) Reticulocyte production index
5
16
3.16
1.44
1.0
2.4
—
—
—
0
0
(21494670) JAK2 gene exon 14 targeted mutation analysis in Blood or Tissue by Molecular genetics method
9
41
2.23
1.38
1.0
1.0
—
—
—
0
0
(3023939) Sjogrens syndrome-A extractable nuclear Ab [Units/volume] in Serum
10
48
2.12
1.29
1.3
1.3
—
46.2
—
0
5
(3002109) Cholesterol in LDL/Cholesterol in HDL [Mass Ratio] in Serum or Plasma
8
160
0.49
1.28
1.1
1.8
—
—
—
0
0
(40759842) Ribonucleoprotein extractable nuclear Ab [Presence] in Serum by Immunoblot
6
25
2.42
1.25
1.0
1.2
—
—
—
0
0
(40759844) Sjogrens syndrome-B extractable nuclear Ab [Presence] in Serum by Immunoblot
6
25
2.42
1.25
1.0
1.2
—
—
—
0
0
(40759836) Histone Ab [Presence] in Serum by Immunoblot
6
25
2.42
1.25
1.0
1.2
—
—
—
0
0
(40759849) Smith extractable nuclear Ab [Presence] in Serum by Immunoblot
6
25
2.42
1.25
1.0
1.2
—
—
—
0
0
(40759843) Sjogrens syndrome-A extractable nuclear Ab [Presence] in Serum by Immunoblot
6
25
2.42
1.25
1.0
1.2
—
—
—
0
0
(40759812) SCL-70 extractable nuclear Ab [Presence] in Serum by Immunoblot
6
25
2.42
1.25
1.0
1.2
—
—
—
0
0
(3018251) Fasting glucose [Moles/volume] in Serum or Plasma
275
2590
1.32
1.23
9.0
5.0
mmol/l
6.7
6.1
4.83
264
2336
(40766189) Gliadin peptide IgG Ab [Units/volume] in Serum by Immunoassay
11
57
1.96
1.18
1.3
1.1
—
16.8
—
0
5
(3017895) Helicobacter pylori Ab [Units/volume] in Serum
15
87
1.76
1.17
1.6
1.6
—
—
—
0
0
(4024509)
5
20
2.52
1.15
2.4
1.2
—
—
—
0
0
(3003740) Influenza virus B Ag [Presence] in Specimen
5
20
2.52
1.15
1.8
1.1
—
—
—
0
0
(3002523) Influenza virus A Ag [Presence] in Specimen
5
20
2.52
1.15
1.8
1.1
—
—
—
0
0
(44816559) Phosphatidylethanol [Mass/volume] in Blood
10
51
1.99
1.12
1.1
1.2
—
—
—
0
0
(3018559) Microscopic observation [Identifier] in Buccal smear by Cyto stain
8
41
1.97
1.09
1.1
1.1
—
—
—
0
0
(3026389) Candida sp identified in Specimen by Organism specific culture
7
33
2.14
1.06
1.0
1.3
—
—
—
0
0
(3013139) Helicobacter pylori Ag [Presence] in Stool
20
130
1.57
1.05
1.3
1.2
—
—
—
0
0
(3051611) Lipemic interference index of Serum or Plasma
7
34
2.08
1.03
11.7
3.5
—
—
—
0
0
(3016543) Leukocytes [#/volume] in Cerebral spinal fluid
9
48
1.90
1.01
1.0
1.2
e6/l
0.6
4.1
—
9
39
(3027475) Erythrocytes [#/volume] in Cerebral spinal fluid
9
48
1.90
1.01
1.3
1.3
e6/l
10.8
2464.8
—
9
39
(3023419) Bacteria identified in Sputum by Culture
9
48
1.90
1.01
3.3
2.8
—
—
—
0
0
(3027545) Mycoplasma pneumoniae Ab [Presence] in Serum by Immunoassay
9
49
1.86
0.99
1.2
1.3
—
—
—
0
0
(3035637) Corticotropin [Mass/volume] in Plasma
5
23
2.19
0.98
1.6
1.3
—
—
—
0
0
(36033641) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Rapid immunoassay
7
37
1.91
0.94
2.1
1.3
—
—
—
0
0
(21494434) Karyotype in Bone marrow
7
37
1.91
0.94
1.0
1.1
—
—
—
0
0
(3014051) Protein [Presence] in Urine by Test strip
10
55
1.84
0.93
7.7
2.2
—
—
—
0
0
(3013603) Prostate specific Ag [Mass/volume] in Serum or Plasma
173
1575
1.20
0.92
4.2
5.2
ug/l
2.4
2.6
0.13
164
1402
(3032155) Metanephrine Free [Moles/volume] in Serum or Plasma
6
29
2.09
0.89
1.3
1.4
—
—
—
0
0
(3027544) Mycobacterium sp identified in Sputum by Organism specific culture
8
42
1.93
0.89
3.9
4.0
—
—
—
0
0
(36660697) Celiac disease serology panel - Serum
22
153
1.47
0.88
1.2
1.2
—
—
—
0
0
(3016650) Hepatitis A virus Ab [Presence] in Serum
8
43
1.88
0.88
1.1
1.1
—
—
—
0
0
(3016701) Glucose [Moles/volume] in Serum or Plasma --2 hours post dose glucose
6
30
2.02
0.87
1.0
1.2
mmol/l
9.6
7.7
—
6
21
(3042111) Morphology [Interpretation] in Bone marrow Narrative
11
64
1.74
0.87
1.4
1.8
—
—
—
0
0
(3008230) Borrelia burgdorferi IgM Ab [Units/volume] in Serum
23
162
1.45
0.87
2.3
2.5
—
14.5
—
0
8
(3027238) Thyroperoxidase Ab [Units/volume] in Serum or Plasma
16
106
1.53
0.80
1.1
1.2
iu/ml
18.6
102.7
—
6
32
(3006257) Acetylcholine receptor Ab [Moles/volume] in Serum
0
24
0.00
0.79
0.0
1.1
—
2.7
—
0
5
(3038177) Helicobacter pylori Ab [Presence] in Serum
6
33
1.83
0.79
1.3
1.2
—
—
—
0
0
(3010380) Borrelia burgdorferi IgG Ab [Units/volume] in Cerebral spinal fluid
5
24
2.10
0.75
1.0
1.1
—
—
—
0
0
(4281824)
5
24
2.10
0.75
1.2
1.0
—
—
—
0
0
(3025577) Chromium [Mass/volume] in Blood
5
25
2.01
0.73
3.2
2.2
ug/l
1.8
2.0
—
5
19
(40762119) U1 small nuclear ribonucleoprotein 70kD Ab [Units/volume] in Serum
5
25
2.01
0.73
1.0
1.1
—
—
—
0
0
(4146454)
5
27
1.86
0.68
4.0
2.8
—
—
—
0
0
(3014973) Borrelia burgdorferi IgM Ab [Units/volume] in Cerebral spinal fluid
5
28
1.80
0.66
1.0
1.1
—
—
—
0
0
(3009340) Metanephrine [Moles/volume] in Serum or Plasma
5
29
1.73
0.64
1.2
1.4
—
—
—
0
0
(3010521) Mycoplasma pneumoniae IgM Ab [Presence] in Serum by Immunoassay
8
49
1.65
0.62
1.0
1.1
—
—
—
0
0
(3000492) Spirometry study
31
245
1.29
0.62
1.6
1.5
—
—
—
0
0
(43054914) Glucose tolerance 2 hours panel - Serum or Plasma
32
255
1.28
0.61
1.3
1.5
—
—
—
0
0
(3040363) Hepatitis A virus IgG Ab [Presence] in Serum by Immunoassay
0
20
0.00
0.60
0.0
1.0
—
—
—
0
0
(3024135) Streptococcus.beta-hemolytic [Presence] in Throat by Organism specific culture
34
275
1.26
0.58
1.2
1.3
—
—
—
0
0
(43534045) MCM6 gene c.-13910C>T and -13915T>G [Identifier] in Blood or Tissue by Molecular genetics method Nominal
13
90
1.46
0.56
1.0
1.0
—
—
—
0
0
(1761868) Lipid panel - Serum or Plasma
95
855
1.15
0.54
6.1
3.1
—
—
—
0
0
(3003031) Transferrin.carbohydrate deficient.disialo/Transferrin.total in Serum or Plasma
33
271
1.24
0.51
1.8
1.8
%
1.9
1.6
0.68
26
231
(1002224) Polysomnography panel
6
93
0.64
0.43
1.2
1.1
—
—
—
0
0
(3041145) Herpes simplex virus IgM Ab [Presence] in Serum by Immunoassay
0
15
0.00
0.41
0.0
1.0
—
—
—
0
0
(3023430) Cat dander IgE Ab [Units/volume] in Serum
0
15
0.00
0.41
0.0
1.1
—
6.5
—
0
5
(1617658) Protocol used for examination of sentinel lymph nodes
0
17
0.00
0.41
0.0
1.1
—
—
—
0
0
(3008898) HLA-B27 [Presence]
8
60
1.34
0.40
1.1
1.1
—
—
—
0
0
(3000764) Benzodiazepines [Presence] in Urine
5
35
1.43
0.39
1.2
1.2
—
—
—
0
0
(3016879) Cocaine [Presence] in Urine
5
35
1.43
0.39
1.0
1.2
—
—
—
0
0
(3027008) Opiates [Presence] in Urine
5
37
1.36
0.37
1.2
1.2
—
—
—
0
0
(3027944) Amphetamines [Presence] in Urine
5
37
1.36
0.37
1.2
1.2
—
—
—
0
0
(3028300) Cannabinoids [Presence] in Urine
5
37
1.36
0.37
1.2
1.2
—
—
—
0
0
(3044290) Cell count panel - Cerebral spinal fluid
6
42
1.44
0.35
1.0
1.2
—
—
—
0
0
(3025839) Triglyceride [Moles/volume] in Serum or Plasma
79
725
1.12
0.34
2.0
1.7
mmol/l
1.8
1.3
3.45
73
609
(3043109) Cytology report of Tissue fine needle aspirate Cyto stain
8
62
1.30
0.28
1.4
1.3
—
—
—
0
0
(3045142) Bone marrow Pathology biopsy report
5
38
1.32
0.23
1.2
1.1
—
—
—
0
0
(3005013) Prostate Specific Ag Free [Mass/volume] in Serum or Plasma
87
921
0.93
0.22
2.9
3.1
ug/l
1.0
0.8
0.80
68
629
(3013327) Hepatitis A virus IgM Ab [Presence] in Serum
5
41
1.22
0.22
1.0
1.0
—
—
—
0
0
(3028531) Enolase.neuron specific [Mass/volume] in Serum or Plasma
5
42
1.19
0.21
3.8
1.6
ug/l
14.0
16.1
—
5
42
(42868414) European tick borne encephalitis virus IgM Ab [Presence] in Serum by Immunoassay
0
11
0.00
0.21
0.0
1.2
—
—
—
0
0
(3036535) Thyroglobulin [Mass/volume] in Serum or Plasma
0
11
0.00
0.21
0.0
5.6
—
—
—
0
0
(3028679) Herpes simplex virus Ab [Presence] in Serum
0
11
0.00
0.21
0.0
1.0
—
—
—
0
0
(3000081) cloZAPine [Moles/volume] in Serum or Plasma
0
10
0.00
0.21
0.0
12.8
—
1619.8
—
0
10
(44816752) ERBB2 gene copy number/nucleus in Tissue by FISH
0
10
0.00
0.21
0.0
1.0
—
—
—
0
0
(3008832) Norclozapine [Moles/volume] in Serum or Plasma
0
10
0.00
0.21
0.0
10.5
—
969.3
—
0
10
(3016894) Varicella zoster virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection
0
12
0.00
0.21
0.0
1.2
—
—
—
0
0
(3030429) Borrelia sp DNA [Identifier] in Specimen by NAA with probe detection
0
13
0.00
0.21
0.0
1.1
—
—
—
0
0
(3049714) Procollagen type I.N-terminal propeptide [Mass/volume] in Serum
0
14
0.00
0.20
0.0
1.8
—
65.9
—
0
14
(3045783) Sodium and Potassium panel [Moles/volume] - Serum or Plasma
31
341
0.90
0.18
27.9
7.7
—
—
—
0
0
(3003510) Neisseria gonorrhoeae DNA [Presence] in Urine by NAA with probe detection
11
91
1.22
0.18
1.4
1.7
—
—
—
0
0
(3004248) Sex hormone binding globulin [Moles/volume] in Serum or Plasma
10
82
1.23
0.17
1.5
1.8
nmol/l
43.0
45.7
—
10
76
(36032419) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Immunoassay
7
63
1.11
0.17
1.9
1.5
—
—
—
0
0
(3046870) Tissue transglutaminase IgG Ab [Units/volume] in Serum
6
78
0.77
0.15
1.0
1.0
—
—
—
0
0
(4034850)
7
88
0.79
0.14
39.0
12.6
—
—
—
0
0
(3018006) Microscopic observation [Identifier] in Cervix by Cyto stain.thin prep
18
160
1.13
0.14
1.4
1.4
—
—
—
0
0
(3024950) Chlamydia trachomatis DNA [Presence] in Urine by NAA with probe detection
12
103
1.17
0.14
1.4
1.9
—
—
—
0
0
(3001784) Prostate Specific Ag Free/Prostate specific Ag.total in Serum or Plasma
125
1275
0.97
0.08
3.6
4.5
%
27.0
21.2
3.72
69
623
(3033319) Streptococcus pyogenes Ag [Presence] in Throat
13
131
0.99
0.00
1.5
1.3
—
—
—
0
0
(3017732) Neutrophils [#/volume] in Blood
17
173
0.98
0.00
3.1
2.7
e9/l
7.7
3.9
—
9
129
(3037677) Mycoplasma pneumoniae IgM Ab [Titer] in Cerebral spinal fluid
0
8
0.00
0.00
0.0
1.1
—
—
—
0
0
(4133840)
0
8
0.00
0.00
0.0
1.3
—
—
—
0
0
(3002823) Mycoplasma pneumoniae IgG Ab [Units/volume] in Cerebral spinal fluid
0
8
0.00
0.00
0.0
1.1
—
—
—
0
0
(3032567) Hepatitis B virus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection
0
8
0.00
0.00
0.0
1.3
—
—
—
0
0
(21492888) Glucose tolerance 2 hours gestational panel - Serum or Plasma
0
8
0.00
0.00
0.0
1.1
—
—
—
0
0
(3015183) Erythrocyte sedimentation rate
0
9
0.00
0.00
0.0
1.3
—
—
—
0
0
(42868499) Enterovirus IgG Ab [Presence] in Cerebral spinal fluid by Immunoassay
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(42868415) European tick borne encephalitis virus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay
0
5
0.00
0.00
0.0
1.2
—
—
—
0
0
(42869547) Procollagen type III.N-terminal propeptide [Mass/volume] in Serum
0
9
0.00
0.00
0.0
1.0
—
8.4
—
0
9
(3050794) Legionella sp Ab [Presence] in Serum
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3009550) Parvovirus B19 IgG Ab [Titer] in Serum
0
6
0.00
0.00
0.0
1.3
—
—
—
0
0
(3000285) Sodium [Moles/volume] in Blood
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
(42528593) TIF1-gamma Ab [Presence] in Serum by Line blot
0
9
0.00
0.00
0.0
1.2
—
—
—
0
0
(3032868) Hemoglobin electrophoresis panel in Blood
0
5
0.00
0.00
0.0
1.6
—
—
—
0
0
(40765096) Chromosome analysis panel by Banding
0
9
0.00
0.00
0.0
1.0
—
—
—
0
0
(3002148) Methylenedioxymethamphetamine [Presence] in Urine by Screen method
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
(3013637) Mi-2 Ab [Presence] in Serum
0
9
0.00
0.00
0.0
1.2
—
—
—
0
0
(3008733) Herpes simplex virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection
0
9
0.00
0.00
0.0
1.1
—
—
—
0
0
(42868421) Varicella zoster virus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay
0
9
0.00
0.00
0.0
1.1
—
—
—
0
0
(3024666) Lithium, Blood [Moles/volume] in Serum or Plasma
0
9
0.00
0.00
0.0
8.8
—
0.6
—
0
9
(3050129) First trimester maternal screen panel - Serum or Plasma
0
5
0.00
0.00
0.0
1.6
—
—
—
0
0
(40761849) Varicella zoster virus IgG Ab [Units/volume] in Cerebral spinal fluid by Immunoassay
0
9
0.00
0.00
0.0
1.1
—
—
—
0
0
(3021162) Amylase [Enzymatic activity/volume] in Specimen
0
7
0.00
0.00
0.0
1.9
—
10996.0
—
0
7
(3012741) Chlamydophila pneumoniae IgA Ab [Titer] in Serum
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3042975) Streptococcus sp identified in Isolate by Organism specific culture
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3020321) Streptococcus agalactiae [Presence] in Vaginal fluid by Organism specific culture
0
7
0.00
0.00
0.0
1.3
—
—
—
0
0
(3037826) lamoTRIgine [Moles/volume] in Serum or Plasma
0
7
0.00
0.00
0.0
2.3
—
14.1
—
0
7
(42529598) SUMO-activating enzyme subunit 1 Ab [Presence] in Serum by Line blot
0
9
0.00
0.00
0.0
1.2
—
—
—
0
0
(3007695) Herpes simplex virus 2 IgG Ab [Presence] in Cerebral spinal fluid
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3015076) Soybean IgE Ab [Units/volume] in Serum
0
7
0.00
0.00
0.0
1.0
—
—
—
0
0
(3026515) Parvovirus B19 IgM Ab [Units/volume] in Serum
0
7
0.00
0.00
0.0
1.3
—
—
—
0
0
(3020650) Glucose [Presence] in Urine
0
9
0.00
0.00
0.0
1.2
—
—
—
0
0
(3044212) Herpes simplex virus 1+2 IgM Ab [Presence] in Cerebral spinal fluid
0
9
0.00
0.00
0.0
1.1
—
—
—
0
0
(42529582) MDA5 Ab [Presence] in Serum by Line blot
0
9
0.00
0.00
0.0
1.2
—
—
—
0
0
(40768800) Prostate Pathology biopsy report
9
92
0.98
0.00
2.1
1.2
—
—
—
0
0
(3031072) Herpes simplex virus 1 IgG Ab [Presence] in Cerebral spinal fluid
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0

Mortality – FinRegistry

↥

Association

Association between endpoint GOUT_KIDNEY and mortality.

Females

Parameter HR [95% CI] p-value
GOUT_KIDNEY 3.249 [2.27, 4.66] < 0.001
Birth year 0.991 [0.98, 1.0] 0.047

During the follow-up period (1.1.1998 — 31.12.2019), 269 out of 519 females with GOUT_KIDNEY died.

Males

Parameter HR [95% CI] p-value
GOUT_KIDNEY 3.409 [2.41, 4.82] < 0.001
Birth year 0.985 [0.98, 0.99] 0.002

During the follow-up period (1.1.1998 — 31.12.2019), 471 out of 1000 males with GOUT_KIDNEY died.

Mortality risk

Mortality risk for people of age

years, who have GOUT_KIDNEY.

N-year risk Females Males
1 0.325% 0.617%
5 1.813% 4.031%
10 4.542% 9.412%
15 8.29% 17.3%
20 14.068% 28.218%

Relationships between endpoints

↥

Index endpoint: GOUT_KIDNEY – Gout due to impairment of renal function

GWS hits: -

Endpoint
Case Overlap
Survival Analysis
Genetic Correlations
Genetic Signals
N (Jaccard index)
HR [CI]
Extremity
rg [CI]
Extremity
Hits
Coloc Hits
FinRegistry
FinnGen
FinRegistry
FinnGen
FinnGen
loading spinner Loading data